Published Reports


DATE COMPANY TITLE SECTOR SYMBOL RATING ANALYST DOCUMENT
July 27, 2015 Avalanche Biotechnologies, Inc. PT to $17.50: CEO resignation on strategic flaws? AGTC preference affirmed Biotechnology and Pharmaceuticals AAVL Neutral Gbola Amusa, MD, CFA Register
July 27, 2015 Esperion Therapeutics, Inc. PT cut to $40; Praluent label reveals multiple negatives for Esperion Biotechnology and Pharmaceuticals ESPR Sell Gbola Amusa, MD, CFA Register
July 27, 2015 Cannabis Legislation Advances in Senate Cannabis JAMES McILREE, CFA Register
July 27, 2015 VistaGen Therapeutics Important positive: Allergan to acquire Naurex, VSTA's closest comp Biotechnology and Pharmaceuticals VSTA Buy Gbola Amusa, MD, CFA Register
July 27, 2015 Axovant Sciences Ltd. A reason why RVT-101 may have cost only $5 million upfront Biotechnology and Pharmaceuticals AXON Sell Gbola Amusa, MD, CFA Register
July 27, 2015 Chardan Global Insights - Jul 27 2015 AAVL AXON CANN ESPR VSTA Chardan Capital Markets Research Register
July 28, 2015 Inphi Corporation Expecting inline or better Q2:15 results; Q3:15 guidance unlikely to disappoint Technology IPHI Buy Jay Srivatsa Register
July 28, 2015 Chardan Global Insights - Jul 28 2015 IPHI Chardan Capital Markets Research Register
July 28, 2015 Esperion Therapeutics, Inc. Phase II shows an imbalance on SAEs (10 on drug, 3 on placebo) (1.4% vs 0.9%) Biotechnology and Pharmaceuticals ESPR Sell Gbola Amusa, MD, CFA Register
July 29, 2015 CEVA Inc, Q2:15 Earnings Preview: Expecting inline results and guidance; Reiterate Buy Technology CEVA Buy Jay Srivatsa Register
July 29, 2015 Inphi Corporation Q2:15 Results Beats Consensus; Guidance Inline But Conservative; Reiterate Buy Technology IPHI Buy Jay Srivatsa Register
July 29, 2015 Chardan Global Insights - Jul 29 2015 CEVA IPHI Chardan Capital Markets Research Register
July 30, 2015 Camtek Q2:15 Earnings Preview Technology CAMT Buy Jay Srivatsa Register
July 30, 2015 Chardan Global Insights - Jul 30 2015 CAMT Chardan Capital Markets Research Register
July 31, 2015 Iridium Communications Inc. Q2 Revenue Lighter than Expected on Dollar Strength and Oil Weakness Telecom Services IRDM Neutral JAMES McILREE, CFA Register
July 31, 2015 CEVA Inc, Impressive Q2:15 Results and Q3:15 Guidance; Reiterate Buy; $21 PT Technology CEVA Buy Jay Srivatsa Register
July 31, 2015 Esperion Therapeutics, Inc. Analyst Day: More SAE visibility, but a death and phase III design raise Qs Biotechnology and Pharmaceuticals ESPR Sell Gbola Amusa, MD, CFA Register
July 31, 2015 DigitalGlobe Inc. Q2 Better than Expected. Commercial Headwinds. Telecom Services DGI Buy JAMES McILREE, CFA Register
July 31, 2015 Chardan Global Insights - Jul 31 2015 CEVA DGI IRDM Chardan Capital Markets Research Register
August 03, 2015 MassRoots, Inc. Initiating Coverage of MassRoots with $2.50 Target Telecom Services MSRT Buy JAMES McILREE, CFA Register
August 03, 2015 PMCB: Intriguing Platform for Delivering Targeted Therapies Therapeutics, Devices & Diagnostics Keay Nakae, CFA Register
August 03, 2015 Integrated Device Technology Inc. Q1:16 Earnings Preview: Expecting Mixed Q1:16 Results and Q2:16 Guidance Technology IDTI Buy Jay Srivatsa Register
August 03, 2015 Alliqua Inc. ALQA:Q2 2015 Earnings Preview Therapeutics, Devices & Diagnostics ALQA Buy Keay Nakae, CFA Register
August 03, 2015 Chardan Global Insights - Aug 03 2015 ALQA IDTI MSRT Chardan Capital Markets Research Register
August 03, 2015 Catalysts this week: ACT, AXON, ESPR, REGN, OPHT, VSTA Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
August 04, 2015 TowerJazz Expecting Q2:15 Results above Consensus; Inline Q3:15 Guidance Technology TSEM Buy Jay Srivatsa Register
August 04, 2015 Perion Networks Inc Impressive Results and Guidance; But Challenges Remain; Maintain Neutral; $4 PT Technology PERI Neutral Jay Srivatsa Register
August 04, 2015 Integrated Device Technology Inc. Impressive Results & Q2:16 Guidance; Designed into iPhone 6S; Raising PT to $32 Technology IDTI Buy Jay Srivatsa Register
August 04, 2015 Chardan Global Insights - Aug 04 2015 IDTI PERI TSEM Chardan Capital Markets Research Register
August 05, 2015 Camtek Impressive Results and Guidance; Delays in Gryphon Shipments Technology CAMT Buy Jay Srivatsa Register
August 05, 2015 Himax Technologies Weak Demand Could Put Q3:15 Consensus Out of Reach; Lowering Estimates Technology HIMX Buy Jay Srivatsa Register
August 05, 2015 Chardan Global Insights - Aug 05 2015 CAMT HIMX Chardan Capital Markets Research Register
August 06, 2015 TowerJazz Returns to GAAP Profitability;Guides to Growing Rev and GMs; Raising PT to $23 Technology TSEM Buy Jay Srivatsa Register
August 06, 2015 22nd Century Group, Inc. Q2 Better than Expected. Telecom Services XXII Buy JAMES McILREE, CFA Register
August 06, 2015 Chardan Global Insights - Aug 06 2015 TSEM XXII Chardan Capital Markets Research Register
August 07, 2015 Alliqua Inc. ALQA: Company Reports Q2 2015 Results Therapeutics, Devices & Diagnostics ALQA Buy Keay Nakae, CFA Register
August 07, 2015 StemCells Inc. STEM: Company Reports Q2 2015 Results Therapeutics, Devices & Diagnostics STEM Buy Keay Nakae, CFA Register
August 07, 2015 Esperion Therapeutics, Inc. Reiterate Sell: The failure of TAK-475 is a concerning signal for ETC-1002 Biotechnology and Pharmaceuticals ESPR Sell Gbola Amusa, MD, CFA Register
August 07, 2015 Max Linear Inc. Strong Cable Demand Suggest Robust Q2:15 Results and Q3:15 Guidance Technology MXL Buy Jay Srivatsa Register
August 07, 2015 ORBCOMM, Inc. Q2 Better Than Expected. OG2 Loses a Satellite Telecom Services ORBC Buy JAMES McILREE, CFA Register
August 07, 2015 Chardan Global Insights - Aug 07 2015 ALQA MXL ORBC STEM Chardan Capital Markets Research Register
August 10, 2015 La Jolla Pharmaceuticals Co. A top pick on multi-layered optionality from upcoming catalysts Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
August 10, 2015 Himax Technologies Move to increase LCoS capacity confirms Microsoft Hololens Win; Reiterate Buy Technology HIMX Buy Jay Srivatsa Register
August 10, 2015 Profire Energy Inc. Fiscal Q1 Preview. Cannabis PFIE Buy JAMES McILREE, CFA Register
August 10, 2015 Azrieli Group Azrieli 2Q15 results preview Real Estate AZRG IT Neutral Lena Rogovin Register
August 10, 2015 Chardan Global Insights - Aug 10 2015 AZRG.IT GSAT HIMX IPAS LJPC KEYW PFIE Chardan Capital Markets Research Register
August 11, 2015 POZEN Inc. POZN: Company Reports Q2 2015 Results Therapeutics, Devices & Diagnostics POZN Buy Keay Nakae, CFA Register
August 11, 2015 MassRoots, Inc. and 22nd Century Group, Inc. Washington State Sales Data. Vapor Corp. and Alternative Delivery Systems Cannabis MSRT and XXII JAMES McILREE, CFA Register
August 11, 2015 Profire Energy Inc. Fiscal Q1 Better than Expected. Cannabis PFIE Buy JAMES McILREE, CFA Register
August 11, 2015 Chardan Global Insights - Aug 11 2015 CANN PFIE POZN Chardan Capital Markets Research Register
August 11, 2015 Energous Corp. Key Milestones and Progress Gives Further Credibility to WATT's Technology Technology WATT Buy Jay Srivatsa Register
August 12, 2015 Aldeyra Therapeutics, Inc. ALDX: Company Reports Q2 2015 Results Therapeutics, Devices & Diagnostics ALDX Buy Keay Nakae, CFA Register
August 12, 2015 Globalstar Inc. Q2 Less Than Expected. TLPS Still Drives Valuation Cannabis GSAT Buy JAMES McILREE, CFA Register
August 12, 2015 Max Linear Inc. Mixed Q2:15 Results But Strong Q3:15 Guidance; Reiterate Buy; $15 PT Technology MXL Buy Jay Srivatsa Register
August 12, 2015 iPass Inc. Q2 Review. Progress Evident in New Strategy. Cannabis IPAS Neutral JAMES McILREE, CFA Register
August 12, 2015 The KEYW Holding Corporation Q2 Review. Still Waiting for Commercial Cyber Cannabis KEYW Neutral JAMES McILREE, CFA Register
August 12, 2015 U.S. Geothermal Inc. Q2 Better than Expected. Guidance Raised Cannabis HTM Neutral JAMES McILREE, CFA Register
August 12, 2015 Chardan Global Insights - Aug 12 2015 ALDX GSAT HTM IPAS KEYW MXL WATT Chardan Capital Markets Research Register
August 13, 2015 Medical Transcription Billing, Corp. MTBC: Reports Q2 2015 Results Therapeutics, Devices & Diagnostics MTBC Buy Keay Nakae, CFA Register
August 13, 2015 EZchip Semiconductor Impressive Q2:15 Results and Guidance; Cisco Risk Remains; Reiterate Neutral Technology EZCH Neutral Jay Srivatsa Register
August 13, 2015 Signal Genetics, Inc. SGNL: Reports Q2 2015 Results Therapeutics, Devices & Diagnostics SGNL Buy Keay Nakae, CFA Register
August 13, 2015 Chardan Global Insights - Aug 13 2015 EZCH MTBC SGNL Chardan Capital Markets Research Register
August 14, 2015 YOU On Demand Holdings, Inc. Another Impressive Quarter as Company Hits Inflection Point; Reiterate Buy Technology YOD Buy Jay Srivatsa Register
August 14, 2015 Nearmap Ltd. nearmap Next-Gen Camera System can Accelerate Imagery Capture in the US Cannabis NEA.AX Buy JAMES McILREE, CFA Register
August 14, 2015 Chardan Global Insights - Aug 14 2015 IDT NEA.AX YOD Chardan Capital Markets Research Register
August 17, 2015 Catasys Inc. CATS: Company Reports Q2 2015 Results Therapeutics, Devices & Diagnostics CATS Buy Keay Nakae, CFA Register
August 17, 2015 Vuzix Corp. Mixed Q2:15 results; Delays in Revenue Ramp; Maintain Buy; $10 PT Technology VUZI Buy Jay Srivatsa Register
August 17, 2015 Vuzix Corp. Mixed Q2:15 results; Delays in Revenue Ramp; Maintain Buy; $7 PT Technology VUZI Buy Jay Srivatsa Register
August 17, 2015 Spherix Update. Cannabis JAMES McILREE, CFA Register
August 17, 2015 Ohr Pharmaceutical, Inc. Upgrade to Buy: There is value in biotech Biotechnology and Pharmaceuticals OHRP Buy Gbola Amusa, MD, CFA Register
August 17, 2015 Chardan Global Insights - Aug 17 2015 AAVL CATS IPM VUZI Chardan Capital Markets Research Register
August 18, 2015 CEVA Inc, Launch of Galaxy Note 5 and S6 Edge + bodes well for CEVA; Reiterate Buy Technology CEVA Buy Jay Srivatsa Register
August 18, 2015 Esperion Therapeutics, Inc. Bear case confirmed, prior guidance missed, CVOT needed for PII indications Biotechnology and Pharmaceuticals ESPR Sell Gbola Amusa, MD, CFA Register
August 18, 2015 Chardan Global Insights - Aug 18 2015 CEVA ESPR Chardan Capital Markets Research Register
August 19, 2015 Azrieli Group 2Q15 results - Inline NOI growth, strong quarterly FFO, our view unchanged Real Estate AZRG IT Neutral Lena Rogovin Register
August 21, 2015 Himax Technologies Chip sector could be hit hard from the slowdown in China Technology HIMX Jay Srivatsa Register
August 21, 2015 Chardan Global Insights - Aug 21 2015 TECH Chardan Capital Markets Research Register
August 24, 2015 TiGenix Inc. Cx601 posts important phase III results for stem cells and Crohn’s disease Biotechnology and Pharmaceuticals TIG.BR Buy Gbola Amusa, MD, CFA Register
August 24, 2015 Chardan Global Insights - Aug 24 2015 TIG.BR Chardan Capital Markets Research Register
August 26, 2015 Nearmap Ltd. Full Year Results. Significant US Investment Agriculture Technology NEA.AX Buy JAMES McILREE, CFA Register
August 26, 2015 Chardan Global Insights - Aug 26 2015 NEA.AX Chardan Capital Markets Research Register
August 27, 2015 Ambarella Inc. Q2:16 Earnings Preview Technology AMBA Neutral Jay Srivatsa Register
August 27, 2015 uniQure N.V. UniQure 2Q results provide visibility on key September to December catalysts Biotechnology and Pharmaceuticals QURE Buy Gbola Amusa, MD, CFA Register
August 27, 2015 Chardan Global Insights - Aug 27 2015 AMBA Chardan Capital Markets Research Register
August 27, 2015 Applied Genetic Technologies Corporation The Biogen milestone makes the "cash-with-catalysts" argument even stronger Biotechnology and Pharmaceuticals AGTC Buy Gbola Amusa, MD, CFA Register
August 31, 2015 22nd Century Group, Inc. Modified Risk Application Value Highlighted by Recent FDA Actions Agriculture Technology XXII Buy JAMES McILREE, CFA Register
August 31, 2015 Esperion Therapeutics, Inc. Another negative: New, innovative competition emerges from MDCO/ALNY Biotechnology and Pharmaceuticals ESPR Sell Gbola Amusa, MD, CFA Register
August 31, 2015 Regeneron Pharmaceuticals, Inc. Downgrade to neutral on valuation Biotechnology and Pharmaceuticals REGN Neutral Gbola Amusa, MD, CFA Register
August 31, 2015 Chardan Global Insights - Aug 31 2015 07:51AM Biotechnology & Pharmaceuticals Steve Urbach Register
September 03, 2015 Gazit Globe Gazit Globe: Growth on urbanization REIT GZT.IT Buy Lena Rogovin Register
September 03, 2015 Amicus Therapeutics, Inc. A FOLD acquisition in the $25-$50 range? Biotechnology and Pharmaceuticals FOLD Buy Gbola Amusa, MD, CFA Register
September 03, 2015 Chardan Global Insights - Sep 03 2015 06:23AM Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
September 04, 2015 MassRoots, Inc. Washington State Sales Data. MassRoots User Growth Agriculture Technology MSRT JAMES McILREE, CFA Register
September 04, 2015 Chardan Global Insights - Sep 04 2015 06:07AM Chardan Capital Markets Research Register
September 08, 2015 Ophthotech Corporation Fovista superiority over REGN's product & 9 other reasons OPHT is our top pick Biotechnology and Pharmaceuticals OPHT Buy Gbola Amusa, MD, CFA Register
September 08, 2015 Immune Pharmaceuticals, Inc. Chardan Global Insights - Sep 08 2015 06:27AM Biotechnology and Pharmaceuticals LJPC Gbola Amusa Register
September 08, 2015 Nanosphere, Inc. NSPH: Initiating Coverage Healthcare NSPH Keay Nakae, CFA Register
September 08, 2015 Immune Pharmaceuticals, Inc. PT to $80 (+33%) on CRH, hepcidin and gentamicin franchises Biotechnology and Pharmaceuticals IMNP Buy Gbola Amusa, MD, CFA Register
September 14, 2015 Globalstar Inc. TLPS Experimental Deployment in Chicago Agriculture Technology GSAT Buy JAMES McILREE, CFA Register
September 14, 2015 The KEYW Holding Corporation Hawkeye G Order from Goodwill Agriculture Technology KEYW Neutral JAMES McILREE, CFA Register
September 15, 2015 uniQUre Inc. Catalyst Alert: Sanfilippo B data to come on 19 September at ESGCT (Helsinki) Biotechnology and Pharmaceuticals QURE Buy Gbola Amusa, MD, CFA Register
September 15, 2015 Immune Pharmaceuticals, Inc. Chardan Global Insights - Sep 15 2015 05:37AM Biotechnology and Pharmaceuticals IMNP Gbola Amusa, MD, CFA Register
September 15, 2015 Amicus INC At the risk of being premature...We downgrade FOLD from Buy to Neutral Biotechnology and Pharmaceuticals FOLD Buy Gbola Amusa, MD, CFA Register
September 16, 2015 Immune Pharmaceuticals, Inc. Chardan Global Insights - Sep 16 2015 Biotechnology and Pharmaceuticals IMNP Gbola Amusa, MD, CFA Register
September 18, 2015 Profire Energy Inc. PF 3100 Introduction Agriculture Technology PFIE Buy JAMES McILREE, CFA Register
September 18, 2015 Chardan Global Insights - Sep 18 Chardan Capital Markets Research Register
September 21, 2015 TowerJazz Highlights from Tower Roadshow. Maintain Buy. Technology, Media & Telecom TSEM Buy Marc Estigarribia Register
September 21, 2015 Vascular Biogenics Ltd. Initiate Buy (PT $25) on VB-111 benefits (OS, CA-125, PFS) in 3 deadly cancers Biotechnology and Pharmaceuticals VBLT Buy Gbola Amusa, MD, CFA Register
September 23, 2015 Signal Genetics, Inc. SGNL: Company Lands Another New Customer For MyPRS Test Therapeutics, Devices & Diagnostics SGNL Buy Keay Nakae, CFA Register
September 24, 2015 Axovant Sciences Ltd. Reiterate Sell: PT to $8 on concerning risks (QT, off target) newly discovered Biotechnology and Pharmaceuticals AXON Sell Gbola Amusa, MD, CFA Register
September 28, 2015 Vuzix Corp. Reiterate Buy and $7 Target Cannabis VUZI Buy JAMES McILREE, CFA Register
September 28, 2015 22nd Century Group, Inc. Modified Risk a Key Value Driver Cannabis XXII Buy JAMES McILREE, CFA Register
September 28, 2015 Chardan Global Insights - Sep 27 2015 22:20PM Agriculture Technology Steve Urbach Register
September 28, 2015 Vascular Biogenics Ltd. An unprecedented 15-month mOS (p=0.048) seen for VB-111 in rGBM at ECC 2015 Biotechnology and Pharmaceuticals VBLT Buy Gbola Amusa, MD, CFA Register
September 28, 2015 Esperion Therapeutics, Inc. Bear case re-confirmed, guidance missed again, amid new CVOT controversies Biotechnology and Pharmaceuticals ESPR Sell Gbola Amusa, MD, CFA Register
September 29, 2015 Finjan Update: Positive Momentum Cannabis JAMES McILREE, CFA Register
September 29, 2015 Chardan Global Insights - Sep 29 2015 09:01AM Chardan Capital Markets Research Register
September 29, 2015 Esperion Therapeutics, Inc. Position closed: Upgrade to Neutral (PT$18) Biotechnology and Pharmaceuticals ESPR Neutral Gbola Amusa, MD, CFA Register
September 29, 2015 Aldeyra Therapeutics, Inc. ALDX: Commences Enrollment in Allergic Conjunctivitis Study Therapeutics, Devices & Diagnostics ALDX Buy Keay Nakae, CFA Register
September 30, 2015 uniQure N.V. A noteworthy result for AMT-110 in Sanfilippo B drives our 14% PT increase Biotechnology and Pharmaceuticals QURE Buy Gbola Amusa, MD, CFA Register
September 30, 2015 Chardan Global Insights - Sep 30 2015 08:38AM Chardan Capital Markets Research Register
October 04, 2015 Amicus Therapeutics, Inc. Upgrade to Buy: A new bull case unfolds, on FOLD's 54% decline Biotechnology and Pharmaceuticals FOLD Buy Gbola Amusa, MD, CFA Register
October 05, 2015 On Spark's result, buy gene therapy companies (QURE, VBLT, AGTC, AAVL) Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
October 06, 2015 Industry Sales Update Agriculture Technology JAMES McILREE, CFA Register
October 06, 2015 Lion Biotechnologies, Inc. LBIO estimate and PT update Biotechnology and Pharmaceuticals LBIO Buy Gbola Amusa, MD, CFA Register
October 06, 2015 Axovant Sciences Ltd. AXON estimates update Biotechnology and Pharmaceuticals AXON Sell Gbola Amusa, MD, CFA Register
October 06, 2015 Esperion Therapeutics, Inc. ESPR estimate update Biotechnology and Pharmaceuticals ESPR Neutral Gbola Amusa, MD, CFA Register
October 06, 2015 La Jolla Pharmaceuticals Co. LJPC estimate update Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
October 06, 2015 Ophthotech Corporation OPHT estimate update Biotechnology and Pharmaceuticals OPHT Buy Gbola Amusa, MD, CFA Register
October 06, 2015 Vascular Biogenics Ltd. VBLT estimate update Biotechnology and Pharmaceuticals VBLT Buy Gbola Amusa, MD, CFA Register
October 06, 2015 VistaGen Therapeutics VSTA estimate update Biotechnology and Pharmaceuticals VSTA Buy Gbola Amusa, MD, CFA Register
October 06, 2015 Regeneron Pharmaceuticals, Inc. REGN estimate & PT update Biotechnology and Pharmaceuticals REGN Neutral Gbola Amusa, MD, CFA Register
October 06, 2015 Immune Pharmaceuticals, Inc. PT update from change in WACC from market movements Biotechnology and Pharmaceuticals IMNP Buy Gbola Amusa, MD, CFA Register
October 07, 2015 Lion Biotechnologies, Inc. PT +33% on positive news: 1) exclusive NIH TIL licence, 2) long-term TIL data Biotechnology and Pharmaceuticals LBIO Buy Gbola Amusa, MD, CFA Register
October 08, 2015 Alony-Hetz Properties & Investments Ltd. ALHE: Diversified real estate play overlooked by foreign investors REIT ALHE.IT Buy Lena Rogovin Register
October 08, 2015 Immune Pharmaceuticals, Inc. PT update from change in WACC from market movements Biotechnology and Pharmaceuticals IMNP Buy Gbola Amusa, MD, CFA Register
October 10, 2015 VistaGen Therapeutics Estimates updated Biotechnology and Pharmaceuticals VSTA Buy Gbola Amusa, MD, CFA Register
October 12, 2015 Esperion Therapeutics, Inc. Evacetrapib's failure: Good news or bad news? Biotechnology and Pharmaceuticals ESPR Neutral Gbola Amusa, MD, CFA Register
October 13, 2015 Immune Pharmaceuticals, Inc. Raising PT 30% on bertilimumab in BP and inflammatory bowel disease (IBD) Biotechnology and Pharmaceuticals IMNP Buy Gbola Amusa, MD, CFA Register
October 13, 2015 Finjan Update: Symantec Stayed. Palo Alto Delays. Industrial Equipment & Services JAMES McILREE, CFA Register
October 13, 2015 Alony-Hetz Properties & Investments Ltd. ALHE: Increases stake in Energix to 71.8% from 68.9% Real Estate ALHE.IT Buy Lena Rogovin Register
October 13, 2015 Chardan Global Insights - Oct 13 2015 07:01AM Chardan Capital Markets Research Register
October 14, 2015 ORBCOMM, Inc. Second Batch of OG2 Closer to Launch Cannabis ORBC Buy JAMES McILREE, CFA Register
October 18, 2015 Gazit Globe GZT: Acquired 5% stake in BR Malls REIT GZT.IT Buy Lena Rogovin Register
October 18, 2015 Alony-Hetz Properties & Investments Ltd. Carr portfolio revaluation to add ILS120-130mn to ALHE 3Q15 pre-tax profit REIT ALHE.IT Buy Lena Rogovin Register
October 19, 2015 Gazit Globe GZT - Highlights from the meeting with new management team REIT GZT.IT Buy Lena Rogovin Register
October 20, 2015 REGENXBIO Inc. Initiate Buy (PT$33): RGNX is defining and driving the future of gene therapy Biotechnology and Pharmaceuticals RGNX Buy Gbola Amusa, MD, CFA Register
October 23, 2015 Check-Cap Ltd. CHEK: Company Reports Q3 2015 Results Therapeutics, Devices & Diagnostics CHEK Buy Keay Nakae, CFA Register
October 23, 2015 Nearmap Ltd. CEO Departs. Lowering Estimates and Target Industrial & Consumer Technology NEA.AX Buy JAMES McILREE, CFA Register
October 23, 2015 Vascular Biogenics Ltd. PT up 10% (to $27.50) on positive phase II thyroid cancer data Biotechnology and Pharmaceuticals VBLT Buy Gbola Amusa, MD, CFA Register
October 23, 2015 Chardan Global Insights - Oct 23 2015 07:22AM Biotechnology & Pharmaceuticals Steve Urbach Register
October 24, 2015 Avalanche Biotechnologies, Inc. Price target change on market movements Biotechnology and Pharmaceuticals AAVL Buy Gbola Amusa, MD, CFA Register
October 26, 2015 Oregon Goes Recreational. USA v MAMM. California MMRSA Industrial & Consumer Technology JAMES McILREE, CFA Register
October 26, 2015 Oregon Goes Recreational. USA v MAMM. California MMRSA Industrial & Consumer Technology JAMES McILREE, CFA Register
October 27, 2015 Frutarom Industries Ltd FRUT: Initiate coverage with ILS142 PT and Neutral rating Real Estate FRUT.IT Neutral Lena Rogovin Register
October 27, 2015 Ophthotech Corporation Sentiment boost: Pivotal phase IIIs confirmed for 4Q16 as enrollment completes Biotechnology and Pharmaceuticals OPHT Buy Gbola Amusa, MD, CFA Register
October 27, 2015 Chardan Global Insights - Oct 26 2015 22:25PM Chardan Capital Markets Research Register
October 27, 2015 Frutarom Industries Ltd FRUT: Initiate coverage with ILS142 PT and Neutral rating Real Estate FRUT.IT Neutral Lena Rogovin Register
October 27, 2015 Iridium Communications Inc. Q3 Preview Industrial & Consumer Technology IRDM Neutral JAMES McILREE, CFA Register
October 27, 2015 Chardan Global Insights - Oct 26 2015 22:25PM Chardan Capital Markets Research Register
October 28, 2015 Integrated Device Technology Inc. Raising Target to $34. Stellar 2Q16 w/ Accretive M&A. Buy IDTI. Technology, Media & Telecom IDTI Buy Marc Estigarribia Register
October 28, 2015 Inphi Corporation Great 3Q Results. China Demand Resumes. Buy. Technology, Media & Telecom IPHI Buy Marc Estigarribia Register
October 28, 2015 Gazit Globe Citycon reports strong 3Q15 FFO and upgrades 2015 guidance Real Estate GZT.IT Buy Lena Rogovin Register
October 28, 2015 Chardan Global Insights - Oct 28 2015 07:37AM Chardan Capital Markets Research Register
October 28, 2015 Energous Corp. Accelerating through its IC Design Flow. Technology Advances. Buy WATT. Technology, Media & Telecom WATT Buy Marc Estigarribia Register
October 28, 2015 Integrated Device Technology Inc. Raising Target to $34. Stellar 2Q16 w/ Accretive M&A. Buy IDTI. Technology, Media & Telecom IDTI Buy Marc Estigarribia Register
October 28, 2015 Inphi Corporation Great 3Q Results. China Demand Resumes. Buy. Technology, Media & Telecom IPHI Buy Marc Estigarribia Register
October 28, 2015 Gazit Globe Citycon reports strong 3Q15 FFO and upgrades 2015 guidance Real Estate GZT.IT Buy Lena Rogovin Register
October 28, 2015 Chardan Global Insights - Oct 28 2015 07:37AM Chardan Capital Markets Research Register
October 28, 2015 Energous Corp. Accelerating through its IC Design Flow. Technology Advances. Buy WATT. Technology, Media & Telecom WATT Buy Marc Estigarribia Register
October 29, 2015 Vuzix Corp. Market Acceptance Accelerating Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
October 29, 2015 Alony-Hetz Properties & Investments Ltd. ALHE: signs MOU to acquire 2 office properties in Boston, positive Real Estate ALHE.IT Buy Lena Rogovin Register
October 29, 2015 Gazit Globe Equity One reports in-line 3Q15 results, on track to meet FY forecasts Real Estate GZT.IT Buy Lena Rogovin Register
October 29, 2015 Chardan Global Insights - Oct 29 2015 06:57AM Chardan Capital Markets Research Register
October 29, 2015 DigitalGlobe Inc. Q3 Preview Industrial & Consumer Technology DGI Buy JAMES McILREE, CFA Register
October 29, 2015 Vuzix Corp. Market Acceptance Accelerating Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
October 29, 2015 Alony-Hetz Properties & Investments Ltd. ALHE: signs MOU to acquire 2 office properties in Boston, positive Real Estate ALHE.IT Buy Lena Rogovin Register
October 29, 2015 Gazit Globe Equity One reports in-line 3Q15 results, on track to meet FY forecasts Real Estate GZT.IT Buy Lena Rogovin Register
October 29, 2015 Chardan Global Insights - Oct 29 2015 06:57AM Chardan Capital Markets Research Register
October 30, 2015 Iridium Communications Inc. Q3 Exceeds Estimates. Guidance Unchanged. NEXT Delayed Industrial & Consumer Technology IRDM Neutral JAMES McILREE, CFA Register
October 30, 2015 DigitalGlobe Inc. Q3 Revenue Miss. Commercial Weak and Expected to Remain Challenging Industrial & Consumer Technology DGI Buy JAMES McILREE, CFA Register
October 30, 2015 Camtek Conservative Quarter. Growth Push to 2016. Technology, Media & Telecom CAMT Buy Marc Estigarribia Register
October 30, 2015 POZEN Inc. POZN: Q3 2015 Earnings Preview Therapeutics, Devices & Diagnostics POZN Buy Keay Nakae, CFA Register
October 30, 2015 Iridium Communications Inc. Q3 Exceeds Estimates. Guidance Unchanged. NEXT Delayed Industrial & Consumer Technology IRDM Neutral JAMES McILREE, CFA Register
October 30, 2015 DigitalGlobe Inc. Q3 Revenue Miss. Commercial Weak and Expected to Remain Challenging Industrial & Consumer Technology DGI Buy JAMES McILREE, CFA Register
October 30, 2015 Camtek Conservative Quarter. Growth Push to 2016. Technology, Media & Telecom CAMT Buy Marc Estigarribia Register
October 30, 2015 POZEN Inc. POZN: Q3 2015 Earnings Preview Therapeutics, Devices & Diagnostics POZN Buy Keay Nakae, CFA Register
October 30, 2015 Chardan Global Insights - Oct 30 2015 07:39AM Chardan Capital Markets Research Register
October 31, 2015 Alliqua Inc. ALQA: Q3 2015 Earnings Preview Healthcare ALQA Buy Keay Nakae, CFA Register
October 31, 2015 Alliqua Inc. ALQA: Q3 2015 Earnings Preview Healthcare ALQA Buy Keay Nakae, CFA Register
November 02, 2015 ORBCOMM, Inc. Q3 Preview Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
November 02, 2015 Dimension Inc Initiate Neutral (PT$13): The Bear Case and the Bull Case Biotechnology and Pharmaceuticals DMTX Neutral Gbola Amusa, MD, CFA Register
November 03, 2015 Opexa Therapeutics, Inc. OPXA: Initiating Coverage Healthcare OPXA:US Buy Keay Nakae, CFA Register
November 03, 2015 Perion Networks Inc Value Play: Turnaround Story to Stabilize Profits next Quarter. Raise to Buy. Technology, Media & Telecom PERI Buy Marc Estigarribia Register
November 03, 2015 Opexa Therapeutics, Inc. OPXA: Initiating Coverage Healthcare OPXA:US Buy Keay Nakae, CFA Register
November 03, 2015 CEVA Inc, Strong Quarter Elevates New Run Rate. Raising Target to $27. Buy CEVA. Technology, Media & Telecom CEVA Buy Marc Estigarribia Register
November 03, 2015 StemCells Inc. STEM: Company Reports Q3 2015 Results Healthcare STEM Buy Keay Nakae, CFA Register
November 03, 2015 Gazit Globe FCR reports in-line 3Q15 results, neutral for GZT Real Estate GZT.IT Buy Lena Rogovin Register
November 03, 2015 Chardan Global Insights - Nov 03 2015 07:10AM Chardan Capital Markets Research Register
November 03, 2015 Perion Networks Inc 3Q15 Results Above Consensus. Buy PERI. Technology, Media & Telecom PERI Neutral Marc Estigarribia Register
November 03, 2015 Azrieli Group AZRG assets trip notes: Senior housing, Modiin, Ayalon Mall, Sarona Real Estate AZRG IT Neutral Lena Rogovin Register
November 03, 2015 ORBCOMM, Inc. Q3 Results Low end of Expectations. Outlook Positive Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
November 03, 2015 iPass Inc. Q3 Preview Industrial & Consumer Technology IPAS Neutral JAMES McILREE, CFA Register
November 03, 2015 ORBCOMM, Inc. Q3 Preview Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
November 03, 2015 Perion Networks Inc Value Play: Turnaround Story to Stabilize Profits next Quarter. Raise to Buy. Technology, Media & Telecom PERI Buy Marc Estigarribia Register
November 04, 2015 The Medicines Company Initiate Buy (PT$50) on the promise of ALN-PCSsc Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
November 05, 2015 Nanosphere, Inc. NSPH: Q3 2015 Earnings Preview Healthcare NSPH Keay Nakae, CFA Register
November 05, 2015 iPass Inc. Q3 Results at low-end of Expectations. Significant Progress on New Strategy Industrial & Consumer Technology IPAS Neutral JAMES McILREE, CFA Register
November 05, 2015 Nanosphere, Inc. NSPH: Q3 2015 Earnings Preview Healthcare NSPH Keay Nakae, CFA Register
November 05, 2015 Camtek Slow and Steady Wins the Race. Expect Upside by 2H16. Buy CAMT. Technology, Media & Telecom CAMT Buy Marc Estigarribia Register
November 05, 2015 iPass Inc. Q3 Results at low-end of Expectations. Significant Progress on New Strategy Industrial & Consumer Technology IPAS Neutral JAMES McILREE, CFA Register
November 06, 2015 ORBCOMM, Inc. Q3 In Line. Outlook Remains Positive. Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
November 06, 2015 Alliqua Inc. ALQA: Revenue Shortfall in Q3 Healthcare ALQA Buy Keay Nakae, CFA Register
November 06, 2015 ORBCOMM, Inc. Q3 In Line. Outlook Remains Positive. Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
November 06, 2015 Alliqua Inc. ALQA: Revenue Shortfall in Q3 Healthcare ALQA Buy Keay Nakae, CFA Register
November 09, 2015 BCommunication Ltd. BCOM: Undervalued leveraged play on Bezeq Real Estate BCOM.IT Buy Lena Rogovin Register
November 09, 2015 Profire Energy Inc. Fiscal Q2 Preview Industrial & Consumer Technology PFIE Buy JAMES McILREE, CFA Register
November 09, 2015 The KEYW Holding Corporation Q3 Preview. Industrial & Consumer Technology KEYW Neutral JAMES McILREE, CFA Register
November 09, 2015 Globalstar Inc. TLPS Update Industrial & Consumer Technology GSAT Buy JAMES McILREE, CFA Register
November 09, 2015 Genius Brands International, Inc. Initiating Coverage with Buy Recommendation. Corrected Comp. Table Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
November 09, 2015 POZEN Inc. POZN: Company Reports Q3 2015 Results Healthcare POZN Buy Keay Nakae, CFA Register
November 09, 2015 Nanosphere, Inc. NSPH: Company Reports Q3 2015 Results Healthcare NSPH Keay Nakae, CFA Register
November 09, 2015 Energous Corp. Validation Received. Wire Free Charging Tech Passes Tests. Buy WATT. Technology, Media & Telecom WATT Buy Marc Estigarribia Register
November 09, 2015 BCommunication Ltd. BCOM: Undervalued leveraged play on Bezeq Real Estate BCOM.IT Buy Lena Rogovin Register
November 09, 2015 The KEYW Holding Corporation Q3 Preview. Industrial & Consumer Technology KEYW Neutral JAMES McILREE, CFA Register
November 09, 2015 Genius Brands International, Inc. Initiating Coverage with Buy Recommendation. Corrected Comp. Table Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
November 09, 2015 POZEN Inc. POZN: Company Reports Q3 2015 Results Healthcare POZN Buy Keay Nakae, CFA Register
November 09, 2015 Nanosphere, Inc. NSPH: Company Reports Q3 2015 Results Healthcare NSPH Keay Nakae, CFA Register
November 09, 2015 Energous Corp. Validation Received. Wire Free Charging Tech Passes Tests. Buy WATT. Technology, Media & Telecom WATT Buy Marc Estigarribia Register
November 09, 2015 Genius Brands International, Inc. Initiating Coverage with Buy Recommendation and $3.50 Price Target Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
November 10, 2015 Himax Technologies Multiple Drivers Fuel Growth, as China Demand Resumes. New Estimates. Buy IPHI. Technology, Media & Telecom HIMX Buy Marc Estigarribia Register
November 10, 2015 The KEYW Holding Corporation Q3 Review-Becoming More Constructive on the Stock. Industrial & Consumer Technology KEYW Neutral JAMES McILREE, CFA Register
November 10, 2015 Himax Technologies Chardan Global Insights - Nov 10 2015 09:26AM Industrial & Consumer Technology HIMX Steve Urbach Register
November 10, 2015 The KEYW Holding Corporation Q3 Review-Becoming More Constructive on the Stock. Industrial & Consumer Technology KEYW Neutral JAMES McILREE, CFA Register
November 10, 2015 Himax Technologies Chardan Global Insights - Nov 10 2015 09:26AM Industrial & Consumer Technology HIMX Steve Urbach Register
November 11, 2015 Profire Energy Inc. Fiscal Q2 Better than Expected. Industrial & Consumer Technology PFIE Buy JAMES McILREE, CFA Register
November 11, 2015 U.S. Geothermal Inc. Q3 Review-Solid Quarter and Outlook Industrial & Consumer Technology HTM Neutral JAMES McILREE, CFA Register
November 11, 2015 22nd Century Group, Inc. Q3 Better than Expected Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
November 11, 2015 Opexa Therapeutics, Inc. OPXA: Company Reports Q3 2015 Results Healthcare OPXA:US Buy Keay Nakae, CFA Register
November 11, 2015 Frutarom Industries Ltd New Acquisition in Savory Flavor Segment Real Estate FRUT.IT Neutral Lena Rogovin Register
November 11, 2015 Chardan Global Insights - Nov 11 2015 07:12AM Chardan Capital Markets Research Register
November 11, 2015 Profire Energy Inc. Fiscal Q2 Better than Expected. Industrial & Consumer Technology PFIE Buy JAMES McILREE, CFA Register
November 11, 2015 22nd Century Group, Inc. Q3 Better than Expected Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
November 11, 2015 Opexa Therapeutics, Inc. OPXA: Company Reports Q3 2015 Results Healthcare OPXA:US Buy Keay Nakae, CFA Register
November 11, 2015 Frutarom Industries Ltd New Acquisition in Savory Flavor Segment Real Estate FRUT.IT Neutral Lena Rogovin Register
November 11, 2015 Chardan Global Insights - Nov 11 2015 07:12AM Chardan Capital Markets Research Register
November 11, 2015 The Medicines Company Positive: ALN-PCSsc data confirm the potential for bi-annual dose regimen Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
November 12, 2015 Gazit Globe Atrium 3Q15 results still affected by poor performance in Russia Real Estate GZT.IT Buy Lena Rogovin Register
November 12, 2015 The Medicines Company The promise of ALN-PCSsc Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
November 12, 2015 Gazit Globe Atrium 3Q15 results still affected by poor performance in Russia Real Estate GZT.IT Buy Lena Rogovin Register
November 12, 2015 The Medicines Company The promise of ALN-PCSsc Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
November 13, 2015 Medical Transcription Billing, Corp. MTBC: Company Reports Q3 2015 Results Healthcare MTBC Buy Keay Nakae, CFA Register
November 13, 2015 Aldeyra Therapeutics, Inc. ALDX: Company Reports Q3 Results Healthcare ALDX Buy Keay Nakae, CFA Register
November 13, 2015 Signal Genetics, Inc. SGNL: Company Reports Q3 2015 Results Healthcare SGNL Buy Keay Nakae, CFA Register
November 13, 2015 The Medicines Company Model publish Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
November 13, 2015 YOU On Demand Holdings, Inc. Exclusive IPTV Agreement with China Network TV. Monetization Opportunity. Technology, Media & Telecom YOD Buy Marc Estigarribia Register
November 13, 2015 Aldeyra Therapeutics, Inc. ALDX: Company Reports Q3 Results Healthcare ALDX Buy Keay Nakae, CFA Register
November 13, 2015 Signal Genetics, Inc. SGNL: Company Reports Q3 2015 Results Healthcare SGNL Buy Keay Nakae, CFA Register
November 13, 2015 The Medicines Company Model publish Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
November 13, 2015 YOU On Demand Holdings, Inc. Exclusive IPTV Agreement with China Network TV. Monetization Opportunity. Technology, Media & Telecom YOD Buy Marc Estigarribia Register
November 15, 2015 Azrieli Group 3Q15 results preview Real Estate AZRG IT Neutral Lena Rogovin Register
November 15, 2015 BCommunication Ltd. BEZQ raises net income 2015FY guidance to ILS 1.7bn from ILS 1.5bn Real Estate BCOM.IT Buy Lena Rogovin Register
November 15, 2015 Alony-Hetz Properties & Investments Ltd. PSP Swiss Property: Good 3Q15; 2015FY EBITDA guidance unchanged at CHF 230 mn Real Estate ALHE.IT Buy Lena Rogovin Register
November 15, 2015 Azrieli Group 3Q15 results preview Real Estate AZRG IT Neutral Lena Rogovin Register
November 15, 2015 BCommunication Ltd. BEZQ raises net income 2015FY guidance to ILS 1.7bn from ILS 1.5bn Real Estate BCOM.IT Buy Lena Rogovin Register
November 15, 2015 Alony-Hetz Properties & Investments Ltd. PSP Swiss Property: Good 3Q15; 2015FY EBITDA guidance unchanged at CHF 230 mn Real Estate ALHE.IT Buy Lena Rogovin Register
November 16, 2015 Vuzix Corp. Q3 Sales Better than Expected. iWear Supply Issues Pushes Sales to the Right Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
November 17, 2015 YOU On Demand Holdings, Inc. IPTV Deal backed by $10M Strategic Investment. Maintain Buy. Technology, Media & Telecom YOD Buy Marc Estigarribia Register
November 17, 2015 MassRoots, Inc. Q3 as Expected. Industrial & Consumer Technology MSRT Buy JAMES McILREE, CFA Register
November 17, 2015 Alony-Hetz Properties & Investments Ltd. CARR acquires a re-development property in Bethesda, Maryland for $106mn Real Estate ALHE.IT Buy Lena Rogovin Register
November 17, 2015 Frutarom Industries Ltd FRUT: 3Q15 preview Real Estate FRUT.IT Neutral Lena Rogovin Register
November 17, 2015 Chardan Global Insights - Nov 17 2015 08:58AM Chardan Capital Markets Research Register
November 17, 2015 Energous Corp. Offering to Prepare for Fulfillment and Growth, as it Transitions. Buy WATT. Technology, Media & Telecom WATT Buy Marc Estigarribia Register
November 17, 2015 YOU On Demand Holdings, Inc. IPTV Deal backed by $10M Strategic Investment. Maintain Buy. Technology, Media & Telecom YOD Buy Marc Estigarribia Register
November 17, 2015 Alony-Hetz Properties & Investments Ltd. CARR acquires a re-development property in Bethesda, Maryland for $106mn Real Estate ALHE.IT Buy Lena Rogovin Register
November 17, 2015 Frutarom Industries Ltd FRUT: 3Q15 preview Real Estate FRUT.IT Neutral Lena Rogovin Register
November 17, 2015 Chardan Global Insights - Nov 17 2015 08:58AM Chardan Capital Markets Research Register
November 17, 2015 Energous Corp. Offering to Prepare for Fulfillment and Growth, as it Transitions. Buy WATT. Technology, Media & Telecom WATT Buy Marc Estigarribia Register
November 18, 2015 Catasys Inc. CATS: Company Reports Q3 Results Healthcare CATS Buy Keay Nakae, CFA Register
November 18, 2015 Chardan Global Insights - Nov 18 2015 08:55AM Chardan Capital Markets Research Register
November 18, 2015 Azrieli Group 3Q15 results in-line, we update forecast on recent developments, PT unchanged Real Estate AZRG IT Neutral Lena Rogovin Register
November 18, 2015 Catasys Inc. CATS: Company Reports Q3 Results Healthcare CATS Buy Keay Nakae, CFA Register
November 18, 2015 Chardan Global Insights - Nov 18 2015 08:55AM Chardan Capital Markets Research Register
November 18, 2015 Azrieli Group 3Q15 results in-line, we update forecast on recent developments, PT unchanged Real Estate AZRG IT Neutral Lena Rogovin Register
November 19, 2015 StemCells Inc. STEM: Positive Interim Cervical Spine Data Healthcare STEM Buy Keay Nakae, CFA Register
November 19, 2015 Frutarom Industries Ltd FRUT: PT upgrade on strong 3Q15 results; maintain Neutral rating Real Estate FRUT.IT Neutral Lena Rogovin Register
November 19, 2015 BCommunication Ltd. BCOM: 3Q15 dividend to be paid up 72% q-o-q Real Estate BCOM.IT Buy Lena Rogovin Register
November 19, 2015 StemCells Inc. STEM: Positive Interim Cervical Spine Data Healthcare STEM Buy Keay Nakae, CFA Register
November 19, 2015 Frutarom Industries Ltd FRUT: PT upgrade on strong 3Q15 results; maintain Neutral rating Real Estate FRUT.IT Neutral Lena Rogovin Register
November 23, 2015 TowerJazz Top Pick. Profitable M&A Strategy Drives Margins. Raising Target: Buy TSEM. Technology, Media & Telecom TSEM Buy Marc Estigarribia Register
March 17, 2016 Spark Inc. 2H16 BLA filing guidance consistent with cautious thesis on SPK-RPE65 timing Biotechnology and Pharmaceuticals ONCE Neutral Gbola Amusa, MD, CFA Register
March 17, 2016 Signal Genetics, Inc. SGNL: Improvement In A Number of Areas Therapeutics, Devices & Diagnostics SGNL Buy Keay Nakae, CFA Register
March 17, 2016 Frutarom Industries Ltd 4Q15 - Hit by forex and one-offs, organic growth strong, maintain neutral view Apparel Retail FRUT.IT Neutral Lena Rogovin Register
March 21, 2016 Alony-Hetz Properties & Investments Ltd. PT upgrade to ILS37 on strong Amot and CARR 4Q15 results and outlook Apparel Retail ALHE.IT Buy Lena Rogovin Register
March 21, 2016 The Medicines Company PT to $65 (+30%) on divestments and cost moderation; US Praluent a likely (+) Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
March 21, 2016 Regeneron Pharmaceuticals, Inc. Why Praluent, in 2016, is reasonably likely to be removed from the US market Biotechnology and Pharmaceuticals REGN Sell Gbola Amusa, MD, CFA Register
March 22, 2016 BCommunication Ltd. 4Q15 results and sale of 4.18% in BEZQ in 1Q16 supportive for future dividends Apparel Retail BCOM.IT Neutral Lena Rogovin Register
March 22, 2016 Ritter Pharmaceuticals, Inc. RTTR: Phase 2b/3 Clinical Trial Enrolls First Patient. Therapeutics, Devices & Diagnostics RTTR Buy Keay Nakae, CFA Register
March 22, 2016 uniQUre Inc. Huntington's preclinical POC data are interesting but (by definition) early Biotechnology and Pharmaceuticals QURE Buy Gbola Amusa, MD, CFA Register
March 23, 2016 Regeneron Pharmaceuticals, Inc. ODYSSEY ESCAPE supports anti-PCSK9 market potential, but AMGN has the US IP Biotechnology and Pharmaceuticals REGN Sell Gbola Amusa, MD, CFA Register
March 24, 2016 Azrieli Group 4Q15 - PT upgrade to ILS161 on higher visibility of pipeline development Apparel Retail AZRG IT Neutral Lena Rogovin Register
March 24, 2016 Recreational and Medical Marijuana Market Updates Industrial Equipment & Services JAMES McILREE, CFA Register
March 27, 2016 StemCells Inc. STEM: Focus Shifts to Next Cervical Spine Injury Data Update Therapeutics, Devices & Diagnostics STEM Buy Keay Nakae, CFA Register
March 27, 2016 Medical Transcription Billing, Corp. MTBC: Continued Declines in Operating Expense Therapeutics, Devices & Diagnostics MTBC Buy Keay Nakae, CFA Register
March 27, 2016 Rami Levy Shivuk Hashikma 4Q15 preview: revenue q-o-q decline on seasonality and security situation Apparel Retail RMLI IT Buy Lena Rogovin Register
March 28, 2016 AveXis, Inc. Initiate Buy (PT$60): AVXS-101 transforms a leading cause of infant mortality Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
March 28, 2016 Fox Wizel Ltd 4Q15- Strong core segment revenue growth means better new stores performance Apparel Retail FOX.IT Buy Lena Rogovin Register
March 29, 2016 Vuzix Corp. Q4 EPS Preview. Cautious in front of Quarter Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
March 31, 2016 Eyegate Pharmaceuticals, Inc. EYEG: Cataract Surgery Data On Deck Therapeutics, Devices & Diagnostics EYEG Buy Keay Nakae, CFA Register
March 31, 2016 Silence Therapeutics PLC Initiate Sell (PT £0.80) on data concerns ahead of April 5 topline results Biotechnology and Pharmaceuticals SLN.LN Sell Madhu Kumar Register
March 31, 2016 Rami Levy Shivuk Hashikma 4Q15 - We revise margins forecast down, but see further sales growth potential Apparel Retail RMLI IT Buy Lena Rogovin Register
March 31, 2016 Vuzix Corp. Q4 Less then Expected. iWear Production Issues Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
April 01, 2016 Silence Therapeutics PLC Reported data discrepancies raise concerns ahead of April 5 topline results Biotechnology and Pharmaceuticals SLN.LN Sell Madhu Kumar Register
April 01, 2016 Aldeyra Therapeutics, Inc. ALDX: Focus Now on Upcoming Data From Anterior Uveitis Study Therapeutics, Devices & Diagnostics ALDX Buy Keay Nakae, CFA Register
April 03, 2016 Novavax, Inc. NVAX: No Need to Be a Hero Healthcare NVAX Neutral Keay Nakae, CFA Register
April 04, 2016 Genius Brands International, Inc. Q4 Results Industrial Equipment & Services GNUS Buy JAMES McILREE, CFA Register
April 04, 2016 Dicerna Inc. Initiate Neutral (PT $5): RNAi firm faces multiple challenges in 2016 Biotechnology and Pharmaceuticals DRNA Neutral Madhu Kumar Register
April 04, 2016 Catasys Inc. CATS: Significant Increase in New Contracts Bodes Well for 2016. Healthcare CATS Buy Keay Nakae, CFA Register
April 04, 2016 Alnylam Inc Initiate Buy (PT $93): RNAi leader steps onto pivotal stage with 2016 catalysts Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
April 05, 2016 U.S. Geothermal Inc. Progress on Growth Strategy Industrial Equipment & Services HTM Neutral JAMES McILREE, CFA Register
April 05, 2016 Silence Therapeutics PLC Thesis confirmed: April 5 data likely to slow Atu027 clinical development Biotechnology and Pharmaceuticals SLN.LN Sell Madhu Kumar Register
April 06, 2016 CaesarStone Sdot-Yam Ltd. Growth acceleration in the US is a key to renewed investor confidence REIT CSTE Buy Lena Rogovin Register
April 06, 2016 CaesarStone Sdot-Yam Ltd. Growth acceleration in the US is a key to renewed investor confidence REIT CSTE Buy Lena Rogovin Register
April 06, 2016 The KEYW Holding Corporation Analyst Meeting on Thursday. Largest Contract in Company's History Announced. Industrial Equipment & Services KEYW Buy JAMES McILREE, CFA Register
April 06, 2016 BioTime, Inc. BTX: Progress on Multiple Initiatives Healthcare BTX Buy Keay Nakae, CFA Register
April 07, 2016 iPass Inc. Targeting One Billion Devices by Year-end 2017 Industrial Equipment & Services IPAS Neutral JAMES McILREE, CFA Register
April 07, 2016 Alnylam Inc Competitor clinical hold potential positive signal for Alnylam TTR franchises Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
April 08, 2016 The KEYW Holding Corporation Bullish Analyst Day. Industrial Equipment & Services KEYW Buy JAMES McILREE, CFA Register
April 11, 2016 Gazit Globe PT downgrade to ILS42, higher direct ownership to improve investor sentiment Apparel Retail GZT.IT Buy Lena Rogovin Register
April 12, 2016 Amicus INC Why FOLD could be bought for >$22.50/share Biotechnology and Pharmaceuticals FOLD Buy Gbola Amusa, MD, CFA Register
April 12, 2016 CaesarStone Sdot-Yam Ltd. Sdot Yam can sell its 32.5% stake in CSTE at up to 40% premium to the market Manufacturing CSTE Buy Lena Rogovin Register
April 13, 2016 Regulus Inc. Initiate Buy (PT $15): MicroRNA therapy firm has disruptive 2016 catalysts Biotechnology and Pharmaceuticals RGLS Buy Madhu Kumar Register
April 13, 2016 Spark Inc. Positive: Identified patent concerns are resolving Biotechnology and Pharmaceuticals ONCE Neutral Gbola Amusa, MD, CFA Register
April 14, 2016 Azrieli Group Sells Sonol for ILS364 mn, in line with a strategy of non-core assets disposal Manufacturing AZRG IT Neutral Lena Rogovin Register
April 15, 2016 Emergent BioSolutions, Inc. EBS: Pure Play Provider of Countermeasures for Public Health Threats Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
April 15, 2016 Regulus Inc. Thesis confirmed: RG-101 data supports disruptive potential in HCV Biotechnology and Pharmaceuticals RGLS Buy Madhu Kumar Register
April 18, 2016 22nd Century Group, Inc. Anandia and the Cannabis Opportunity Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
April 18, 2016 22nd Century Group, Inc. Continued Positive Progress but Are Industry Estimates Too Aggressive? Industrial & Consumer Technology XXII JAMES McILREE, CFA Register
April 26, 2016 AB Science S.A. AB.PA: Interim Results From Phase 3 ALS Study Could be Game Changer. Therapeutics, Devices & Diagnostics AB.PA Buy Keay Nakae, CFA Register
April 26, 2016 DigitalGlobe Inc. Q1 Preview. Industrial & Consumer Technology DGI Neutral JAMES McILREE, CFA Register
April 27, 2016 Iridium Communications Inc. Q1 Preview Industrial & Consumer Technology IRDM Neutral JAMES McILREE, CFA Register
April 28, 2016 DigitalGlobe Inc. Q1 Much Stronger than Expected. Guidance Unchanged Industrial & Consumer Technology DGI Neutral JAMES McILREE, CFA Register
April 29, 2016 Iridium Communications Inc. Q1 Better than Expected on Strong Cost Control Industrial & Consumer Technology IRDM Neutral JAMES McILREE, CFA Register
April 29, 2016 Aralez Pharmaceuticals Inc. ARLZ: Q3 2016 Earnings Preview Therapeutics, Devices & Diagnostics Aralez Buy Keay Nakae, CFA Register
May 01, 2016 Gazit Globe Subsidiaries update: EQY and CTY 1Q16 results, FCR/Urbancorp Manufacturing GZT.IT Buy Lena Rogovin Register
May 02, 2016 Genius Brands International, Inc. Recent Announcements Highlight Value of GNUS Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
May 02, 2016 Regeneron Pharmaceuticals, Inc. Negative fasinumab data: Safety, 1-point WOMAC changes, lack of dose-response Biotechnology and Pharmaceuticals REGN Sell Gbola Amusa, MD, CFA Register
May 02, 2016 22nd Century Group, Inc. Annual Meeting Highlights Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
May 03, 2016 CaesarStone Sdot-Yam Ltd. 1Q16 preview: Growth slowdown expected, but should pick up later in 2016 Manufacturing CSTE Buy Lena Rogovin Register
May 03, 2016 Azrieli Group Enters e-commerce segment via buying BUY2 platform for ILS62 mn Manufacturing AZRG IT Neutral Lena Rogovin Register
May 04, 2016 Earnings This Week: iPass, ORBCOMM, KVH Industries, Globalstar Industrial & Consumer Technology JAMES McILREE, CFA Register
May 04, 2016 CaesarStone Sdot-Yam Ltd. 1Q16: Margins decline, slow US growth, strong Australia and Canada sales Manufacturing CSTE Buy Lena Rogovin Register
May 05, 2016 Alnylam Pharmaceuticals, Inc. Competitor platelet concerns reinforce positive signal for ALNY Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
May 05, 2016 Novavax, Inc. NVAX: Moving Closer to Important Phase 3 Study Results For RSV Vaccine Therapeutics, Devices & Diagnostics NVAX Neutral Keay Nakae, CFA Register
May 05, 2016 iPass Inc. Q1 Review. Incrementally Positive on the Shares. Industrial & Consumer Technology IPAS Neutral JAMES McILREE, CFA Register
May 06, 2016 Emergent BioSolutions, Inc. EBS: Renewal of Contract With CDC For Biothrax is Positive and Negative Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
May 06, 2016 ORBCOMM, Inc. Q1 Review. In Line Results. Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
May 06, 2016 KVH Industries Inc. Managing Well Through a Challenging Environment Industrial & Consumer Technology KVHI Buy JAMES McILREE, CFA Register
May 09, 2016 AveXis, Inc. New data at ASGCT reinforces the potentially breakthrough nature of AVXS-101 Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
May 09, 2016 Aldeyra Therapeutics, Inc. ALDX: Positive Data for NS2 in Phase 2 Anterior Uveitis Study. Therapeutics, Devices & Diagnostics ALDX Buy Keay Nakae, CFA Register
May 10, 2016 REGENXBIO Inc. RGNX: PT to $35 (+25%) on potentially landmark AVXS-101 data in SMA type 1 Biotechnology and Pharmaceuticals RGNX Buy Gbola Amusa, MD, CFA Register
May 10, 2016 Mesoblast Limited MESO: Key Clinical Trials Advance Towards Important Data Releases Therapeutics, Devices & Diagnostics MESO Neutral Keay Nakae, CFA Register
May 10, 2016 The KEYW Holding Corporation Q1 Preview. Raise Target to $12 Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
May 10, 2016 Ritter Pharmaceuticals, Inc. RTTR: Phase 2b/3 Clinical Study Moves Forward Therapeutics, Devices & Diagnostics RTTR Buy Keay Nakae, CFA Register
May 11, 2016 uniQUre Inc. AAV re-treatment data reveal QURE's early focus on a potential regulatory issue Biotechnology and Pharmaceuticals QURE Buy Gbola Amusa, MD, CFA Register
May 11, 2016 Alliqua Inc. ALQA: Trying to See The Forrest Through The Trees With Q1 Results Therapeutics, Devices & Diagnostics ALQA Buy Keay Nakae, CFA Register
May 11, 2016 Aralez Pharmaceuticals Inc. ARLZ: Inching Closer to YOSPRALA Approval Therapeutics, Devices & Diagnostics Aralez Buy Keay Nakae, CFA Register
May 11, 2016 Regulus Therapeutics, Inc. Attacking the RG-101 bear case Biotechnology and Pharmaceuticals RGLS Buy Madhu Kumar Register
May 11, 2016 BioTime, Inc. BTX: Clinical Trial Activity Heats Up Therapeutics, Devices & Diagnostics BTX Buy Keay Nakae, CFA Register
May 11, 2016 The KEYW Holding Corporation Q1 Exceeds Expectations. Maintain Buy Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
May 11, 2016 U.S. Geothermal Inc. US Geothermal Q1 as Expected Industrial & Consumer Technology HTM Neutral JAMES McILREE, CFA Register
May 11, 2016 Medical Transcription Billing, Corp. MTBC: Businesses Development Activity Heating Up Therapeutics, Devices & Diagnostics MTBC Buy Keay Nakae, CFA Register
May 12, 2016 U.S. Geothermal Inc. Company Development Programs Remain on Track Industrial & Consumer Technology HTM Neutral JAMES McILREE, CFA Register
May 13, 2016 Vuzix Corp. Vuzi Q1 Impacted by Production Issues and Product Transition Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
May 15, 2016 Rami Levy Shivuk Hashikma Raises bid for Mega to ILS322mn, faces tough competition for the asset Manufacturing RMLI IT Buy Lena Rogovin Register
May 16, 2016 Arbutus. Inc. Initiate Sell (PT $3.25): Competition raises hurdles ahead of 2H16 catalysts Biotechnology and Pharmaceuticals ABUS Sell Madhu Kumar Register
May 16, 2016 Opexa Therapeutics, Inc. OPXA: Moving Closer to Key MS Clinical Trial Data Readout Therapeutics, Devices & Diagnostics OPXA Buy Keay Nakae, CFA Register
May 16, 2016 Eyegate Pharmaceuticals, Inc. EYEG: Data From Two Studies Expected by Mid-year Therapeutics, Devices & Diagnostics EYEG Buy Keay Nakae, CFA Register
May 16, 2016 Globalstar Inc. TLPS Pending Commission Action Industrial & Consumer Technology GSAT Buy JAMES McILREE, CFA Register
May 16, 2016 Vuzix Corp. 2H New Products Expected to Result in Accelerated Growth. Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
May 16, 2016 22nd Century Group, Inc. Q1 Results. Substantial Value in Cannabinoid Research Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
May 16, 2016 Immune Pharmaceuticals, Inc. IMNP: Dropping Coverage Biotechnology and Pharmaceuticals IMNP Buy Gbola Amusa, MD, CFA Register
May 16, 2016 Signal Genetics, Inc. SGNL: Company Returns to Positive Revenue Growth Therapeutics, Devices & Diagnostics SGNL Buy Keay Nakae, CFA Register
May 16, 2016 Ohr Pharmaceutical, Inc. OHRP: Dropping Coverage Biotechnology and Pharmaceuticals OHRP Neutral Gbola Amusa, MD, CFA Register
May 16, 2016 Catasys Inc. CATS: Company Reports Q1 Results Therapeutics, Devices & Diagnostics CATS Buy Keay Nakae, CFA Register
May 17, 2016 Dicerna Pharmaceuticals, Inc. Negative: New DsiRNA-EX preclinical data inferior to clinical competitors Biotechnology and Pharmaceuticals DRNA Neutral Madhu Kumar Register
May 17, 2016 Alony-Hetz Properties & Investments Ltd. 1Q16 results support our FY forecasts Manufacturing ALHE.IT Buy Lena Rogovin Register
May 18, 2016 ORBCOMM, Inc. Bullish Investor Day Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
May 18, 2016 Alony-Hetz Properties & Investments Ltd. ALHE/CARR Investor Day: We remain bullish on ALHE US business Manufacturing ALHE.IT Buy Lena Rogovin Register
May 19, 2016 Arrowhead Initiate Buy (PT $12): Five reasons ARWR is the hepatitis B RNAi therapy leader Biotechnology and Pharmaceuticals ARWR Buy Madhu Kumar Register
May 19, 2016 Spark ONCE, PFE: Impressive and clear (early) results in hemophilia B gene therapy Biotechnology and Pharmaceuticals ONCE Neutral Gbola Amusa, MD, CFA Register
May 20, 2016 Check-Cap Ltd. CHEK: Clinical Timelines Pushed Out Further Therapeutics, Devices & Diagnostics CHEK Buy Keay Nakae, CFA Register
May 22, 2016 Frutarom Industries Ltd 1Q16 preview: Wiberg consolidation - strong revenue growth but lower margins Manufacturing FRUT.IT Neutral Lena Rogovin Register
May 22, 2016 Azrieli Group 1Q16 preview: Focus on same-property NOI growth and pre-lease progress Manufacturing AZRG IT Neutral Lena Rogovin Register
May 23, 2016 U.S. Geothermal Inc. $20M Debt Financing Secured for Development Projects Industrial & Consumer Technology HTM Neutral JAMES McILREE, CFA Register
May 23, 2016 The KEYW Holding Corporation $460M Cybercomm IDIQ Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
May 23, 2016 Asterias Biotherapeutics, Inc. and OncoCyte Corporation AST: Advancing Pioneering Cell Therapy Programs Therapeutics, Devices & Diagnostics AST and OCX Buy Keay Nakae, CFA Register
May 23, 2016 Asterias Biotherapeutics, Inc. and OncoCyte Corporation AST: Advancing Pioneering Cell Therapy Programs Therapeutics, Devices & Diagnostics AST and OCX Buy Keay Nakae, CFA Register
May 24, 2016 Sage Therapeutics, Inc. Initiate Sell (PT$18) on scant evidence SAGE-547 works better than old drugs Biotechnology and Pharmaceuticals SAGE Sell Gbola Amusa, MD, CFA Register
May 24, 2016 Ituran Location and Control Ltd 1Q16: Strong revenue growth in Israel, PT up to $25 on DCF time adjustments Manufacturing ITRN Buy Lena Rogovin Register
May 24, 2016 Frutarom Industries Ltd 1Q16: Strong LFL revenue growth, margins hit by one-offs Manufacturing FRUT.IT Neutral Lena Rogovin Register
May 24, 2016 Asterias Biotherapeutics, Inc. AST: Safety of AST-OPC1 Reaffirmed by Long-Term Follow-up Data Therapeutics, Devices & Diagnostics AST Buy Keay Nakae, CFA Register
May 25, 2016 Azrieli Group 1Q16: NOI in-line, FFO stronger on low tax, PT upgrade by 3% on revaluations Manufacturing AZRG IT Neutral Lena Rogovin Register
May 25, 2016 Gazit Globe 1Q16 preview - Surprises unlikely, focus on management strategy updates Manufacturing GZT.IT Buy Lena Rogovin Register
May 26, 2016 IDI, Inc. Expect Strong 2H from Fluent Momentum and Release of CORE Industrial & Consumer Technology IDI Buy JAMES McILREE, CFA Register
May 26, 2016 The KEYW Holding Corporation Another Prime Contract IDIQ Win Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
May 26, 2016 BCommunication Ltd. 1Q16: Net loss on interest costs and low BEZQ NI, but will pay high dividends Manufacturing BCOM.IT Neutral Lena Rogovin Register
May 26, 2016 Gazit Globe 1Q16: FFO decline q-o-q on one-offs and Dori, no strategy updates Manufacturing GZT.IT Buy Lena Rogovin Register
May 26, 2016 Alnylam Pharmaceuticals, Inc. PT to $115 (+24%) after ALNY competitor IONS halts phase 3 TTR-FAC study Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
May 27, 2016 Profire Energy Inc. $2 Million Share Buyback Authorized Industrial & Consumer Technology PFIE Neutral JAMES McILREE, CFA Register
May 29, 2016 Rami Levy Shivuk Hashikma 1Q16 preview: Focus on same store revenue dynamics and margins Manufacturing RMLI IT Buy Lena Rogovin Register
May 30, 2016 Fox Wizel Ltd 1Q16: Losses on seasonality, PT down to ILS67 on lower margins forecasts Manufacturing FOX.IT Buy Lena Rogovin Register
May 31, 2016 Alnylam Upside risk ahead: Platelet safety concerns exist for the broader IONS pipeline Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
May 31, 2016 KVH Industries Inc. Lower to Neutral Industrial & Consumer Technology KVHI Neutral JAMES McILREE, CFA Register
May 31, 2016 Rami Levy Shivuk Hashikma 1Q16: Strong profitability on slower revenue growth Manufacturing RMLI IT Buy Lena Rogovin Register
May 31, 2016 StemCells Inc. STEM: Dropping Coverage Therapeutics, Devices & Diagnostics STEM D Keay Nakae, CFA Register
June 01, 2016 22nd Century Group, Inc. Legislative, Regulatory, and Market Update Industrial & Consumer Technology XXII JAMES McILREE, CFA Register
June 01, 2016 Regulus Therapeutics, Inc. Positive: Expanded GSK program has potential for disruptive 1-visit HCV therapy Biotechnology and Pharmaceuticals RGLS Buy Madhu Kumar Register
June 02, 2016 The Medicines Company Positive: Early completion of patient enrollment for ALN-PCSsc phase II study Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
June 03, 2016 Globalstar Inc. Pai Votes No Industrial & Consumer Technology GSAT Buy JAMES McILREE, CFA Register
June 03, 2016 Lion Biotechnologies, Inc. Positive: New, experienced management Biotechnology and Pharmaceuticals LBIO Buy Gbola Amusa, MD, CFA Register
June 06, 2016 Regeneron Pharmaceuticals, Inc. A puzzling evinacumab presentation in homozygous familial hypercholesterolemia Biotechnology and Pharmaceuticals REGN Sell Gbola Amusa, MD, CFA Register
June 06, 2016 Vascular Biogenics Ltd. VBLT ASCO 2016 data in rGBM provides visibility to unprecedented data Biotechnology and Pharmaceuticals VBLT Buy Gbola Amusa, MD, CFA Register
June 07, 2016 AB Science S.A. AB.PA: Company to File For Conditional Approval With EMA for ALS Therapeutics, Devices & Diagnostics AB.PA Buy Keay Nakae, CFA Register
June 07, 2016 Vascular Biogenics Ltd. Positive: OS benefit for VB-111 in platinum-resistant ovarian CA at ASCO 2016 Biotechnology and Pharmaceuticals VBLT Buy Gbola Amusa, MD, CFA Register
June 07, 2016 Regulus Therapeutics, Inc. PT to $20 (+33%) after potentially breakthrough 4-week SVR12 results in HCV Biotechnology and Pharmaceuticals RGLS Buy Madhu Kumar Register
June 08, 2016 Regeneron Pharmaceuticals, Inc. Negative: Amgen reply brief poses risk of Praluent removal from US market Biotechnology and Pharmaceuticals REGN Sell Gbola Amusa, MD, CFA Register
June 08, 2016 Adverum ADVM: Downgrade to Neutral (PT$5) and returning to cautionary stance Biotechnology and Pharmaceuticals ADVM Neutral Gbola Amusa, MD, CFA Register
June 08, 2016 Sage Therapeutics, Inc. Phase I data show SAGE-217 is another oral GABAA receptor modulator Biotechnology and Pharmaceuticals SAGE Sell Gbola Amusa, MD, CFA Register
June 09, 2016 Arrowhead Pharmaceuticals, Inc. Positive: ARC-521 phase I/II trial launch reinforces ARWR's HBV RNAi leadership Biotechnology and Pharmaceuticals ARWR Buy Madhu Kumar Register
June 09, 2016 Alnylam Pharmaceuticals, Inc. Positive: Clinical trial launch of second generation TTR drug Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
June 10, 2016 Vuzix Corp. New Products Drive Second Half Growth Industrial Equipment & Services VUZI Buy JAMES McILREE, CFA Register
June 13, 2016 Globalstar Inc. Lower Recommendation to Neutral Industrial & Consumer Technology GSAT Neutral JAMES McILREE, CFA Register
June 13, 2016 Profire Energy Inc. Fiscal Q4 Preview Industrial & Consumer Technology PFIE Neutral JAMES McILREE, CFA Register
June 13, 2016 BioTime, Inc. BTX: Advancing to 2nd Patient Cohort in Dry AMD Study Therapeutics, Devices & Diagnostics BTX Buy Keay Nakae, CFA Register
June 13, 2016 Sage Therapeutics, Inc. Negative: SAGE-547 analogue, ganaxolone, fails in drug-resistant seizures Biotechnology and Pharmaceuticals SAGE Sell Gbola Amusa, MD, CFA Register
June 14, 2016 Regeneron Pharmaceuticals, Inc. New reasons Praluent could be removed from the US market in 2016 Biotechnology and Pharmaceuticals REGN Sell Gbola Amusa, MD, CFA Register
June 14, 2016 Profire Energy Inc. Q4 Revenue Shy of Estimates. Excellent Cost Control Industrial & Consumer Technology PFIE Neutral JAMES McILREE, CFA Register
June 15, 2016 AB Science S.A. AB.PA: Key Takeaways From ALS KOL Meeting Therapeutics, Devices & Diagnostics AB.PA Buy Keay Nakae, CFA Register
June 15, 2016 Profire Energy Inc. Industry Weakness Continues to Impact Results. Possible Second Half Recovery Industrial & Consumer Technology PFIE Neutral JAMES McILREE, CFA Register
June 16, 2016 Arbutus Biopharma Corporation Upgrade to Neutral on 35%+ underperformance vs. ARWR, S&P Biotech Index Biotechnology and Pharmaceuticals ABUS Neutral Madhu Kumar Register
June 17, 2016 Genius Brands International, Inc. Global Netflix Deal for Llama Llama Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
June 20, 2016 ProQR Therapeutics NV Initiate Neutral (PT $4.50): Competitive risks ahead of mid/late-16 catalysts Biotechnology and Pharmaceuticals PRQR Neutral Madhu Kumar Register
June 22, 2016 Vuzix Corp. Notes from Annual Meeting. Reiterate Buy and $10 Target Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
June 22, 2016 NICE-Systems Ltd. Play on growing demand for real time customer analytics and cloud solutions Manufacturing NICE Buy Lena Rogovin Register
June 22, 2016 Applied Genetic Technologies Corporation AGTC's research day: Our key takeaways Biotechnology and Pharmaceuticals AGTC Buy Gbola Amusa, MD, CFA Register
June 22, 2016 Vuzix Corp. Notes from Annual Meeting. Reiterate Buy and $10 Target Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
June 23, 2016 Emergent BioSolutions, Inc. EBS: We Believe Sell-off Creates Buying Opportunity Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
June 28, 2016 Regulus Therapeutics, Inc. PT to $13.50 (-33%) after start of clinical hold for RG-101 in HCV Biotechnology and Pharmaceuticals RGLS Buy Madhu Kumar Register
June 29, 2016 Esperion Therapeutics, Inc. Caution warranted: FDA intolerant of statin intolerance label Biotechnology and Pharmaceuticals ESPR Neutral Gbola Amusa, MD, CFA Register
June 29, 2016 Opexa Therapeutics, Inc. OPXA: Abili-T MS Study on Track Healthcare OPXA Buy Keay Nakae, CFA Register
June 29, 2016 Key takeaways from drug pricing KOL meeting Biotechnology and Pharmaceuticals Madhu Kumar Register
June 30, 2016 Dicerna Pharmaceuticals, Inc. PT to $4 (-20%) for data a GalXC far, far away from the clinic Biotechnology and Pharmaceuticals DRNA Neutral Madhu Kumar Register
July 01, 2016 Vuzix Corp. M300 Shipments Begin Industrial Equipment & Services VUZI Buy JAMES McILREE, CFA Register
July 01, 2016 Alnylam Pharmaceuticals, Inc. Positive (patisiran) and mixed (revusiran) results in open-label extension data Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
July 03, 2016 Gazit Globe Takes profit in BR Malls and inreases investment in Gazit Brazil portfolio Manufacturing GZT.IT Buy Lena Rogovin Register
July 06, 2016 Vuzix Corp. $5M+ Raise Industrial Equipment & Services VUZI Buy JAMES McILREE, CFA Register
July 06, 2016 ProQR Therapeutics NV Negative: Vertex/Moderna agreement creates new competition in CF RNA therapy Biotechnology and Pharmaceuticals PRQR Neutral Madhu Kumar Register
July 08, 2016 Arbutus Biopharma Corporation Downgrade to Sell (PT $2.75): Competition from Alnylam undermines ARB-1467 Biotechnology and Pharmaceuticals ABUS Sell Madhu Kumar Register
July 08, 2016 Alliqua Inc. ALQA: Company Makes Tactical Move With Divestiture of Sorbion Product Healthcare ALQA Buy Keay Nakae, CFA Register
July 11, 2016 Akari Therapeutics PLC Initiate Sell (PT $5): Dosing, competition pose risks before 2H16 catalysts Biotechnology and Pharmaceuticals AKTX Sell Madhu Kumar Register
July 12, 2016 Lion Biotechnologies, Inc. Lion roaring in new directions, with newly-appointed CEO, Maria Fardis Biotechnology and Pharmaceuticals LBIO Buy Gbola Amusa, MD, CFA Register
July 12, 2016 Sage Therapeutics, Inc. Potentially clear, positive top-line phase II data in severe PPD, BUT... Biotechnology and Pharmaceuticals SAGE Sell Gbola Amusa, MD, CFA Register
July 13, 2016 BioTime, Inc. AST: Cervical Spine Injury Study Progressing Nicely Therapeutics, Devices & Diagnostics BTX Buy Keay Nakae, CFA Register
July 14, 2016 Achillion Pharmaceuticals, Inc. Initiate Sell (PT $4): Lack of data, tough competition pose risks to pipeline Biotechnology and Pharmaceuticals ACHN Sell Madhu Kumar Register
July 14, 2016 Alnylam Pharmaceuticals, Inc. IONS R&D Day fails to provide visibility on platelets, TTR-FAC program Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
July 14, 2016 Gazit Globe CTY 2Q16 supported by Sektor and Sweden performance, neutral for GZT Manufacturing GZT.IT Buy Lena Rogovin Register
July 18, 2016 Highlights from QURE roadshow: New team, Highlights from QURE roadshow: New team, important upcoming catalysts Biotechnology and Pharmaceuticals QURE Buy Gbola Amusa, MD, CFA Register
July 18, 2016 Chardan: Viral news in gene therapy (10-16 July 2016) Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
July 19, 2016 AB Science S.A. AB.PA: New Developments in ALS Space Therapeutics, Devices & Diagnostics AB.PA Buy Keay Nakae, CFA Register
July 19, 2016 ProQR Therapeutics NV QR-010 Fast Track is positive but commonplace in delF508 cystic fibrosis Biotechnology and Pharmaceuticals PRQR Neutral Madhu Kumar Register
July 20, 2016 Sage Therapeutics, Inc. Unanswered SAGE-547 questions remain, after further emails to management Biotechnology and Pharmaceuticals SAGE Sell Gbola Amusa, MD, CFA Register
July 20, 2016 AveXis, Inc. Positive: AVXS-101 granted Breakthrough Therapy Designation in SMA type 1 Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
July 21, 2016 Spark Inc. Positive: SPK-9001 receives Breakthrough Therapy Designation in hemophilia B Biotechnology and Pharmaceuticals ONCE Neutral Gbola Amusa, MD, CFA Register
July 23, 2016 Abtech Holdings Inc. Dropping Coverage Industrial & Consumer Technology ABHD D JAMES McILREE, CFA Register
July 24, 2016 Viral news in gene therapy (17-23 July 2016): Gene therapy breaks through twice Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
July 25, 2016 Regulus Therapeutics, Inc. PT to $12 on scenario analysis of coming risks for RG-101 Biotechnology and Pharmaceuticals RGLS Buy Madhu Kumar Register
July 26, 2016 NICE-Systems Ltd. 2Q16 results preview Manufacturing NICE Buy Lena Rogovin Register
July 26, 2016 Spark Inc. ONCE, PFE: hemophilia B gene therapy results continue to impress at WFH Biotechnology and Pharmaceuticals ONCE Neutral Gbola Amusa, MD, CFA Register
July 26, 2016 Alnylam Pharmaceuticals, Inc. Net positive: Fitusiran phase I data demonstrates efficacy in hemophilia A/B Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
July 26, 2016 Hemophilia: WFH update, Days 1 and 2 (ALNY, ONCE, PFE) Biotechnology and Pharmaceuticals Madhu Kumar Register
July 26, 2016 22nd Century Group, Inc. $5 Million Capital Raise Eliminates Financing Overhang Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
July 27, 2016 Hemophilia: WFH update, day 3 (hemophilia in 2030, Expression, SGMO) Biotechnology and Pharmaceuticals Madhu Kumar Register
July 28, 2016 Hemophilia: WFH update, day 4 (NVO, ROG.VX, ALNY, ONCE, BMRN, QURE) Biotechnology and Pharmaceuticals Madhu Kumar Register
July 28, 2016 Vuzix Corp. Shares down on weak short story. Reiterate Buy. Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
July 28, 2016 Iridium Communications Inc. Q2 Results in Line Industrial & Consumer Technology IRDM Neutral JAMES McILREE, CFA Register
July 28, 2016 NICE-Systems Ltd. 2Q16: Strong margins, upgrade PT to $72 on higher EPS guidance and target P/E Manufacturing NICE Buy Lena Rogovin Register
July 28, 2016 Regulus Therapeutics, Inc. FDA letter provides visibility on path for lifting the RG-101 clinical hold Biotechnology and Pharmaceuticals RGLS Buy Madhu Kumar Register
July 28, 2016 Gazit Globe EQY reports 2Q16, cuts FY EPS guidance, but FFO and NOI forecast unchanged Manufacturing GZT.IT Buy Lena Rogovin Register
July 28, 2016 uniQure N.V. Though not the likely hemB GT leader, can uniQure FIX competitor limitations? Biotechnology and Pharmaceuticals QURE Buy Gbola Amusa, MD, CFA Register
July 29, 2016 DigitalGlobe Inc. Q2 Better than Expected. Increased Guidance for the Year Industrial & Consumer Technology DGI Neutral JAMES McILREE, CFA Register
July 31, 2016 Viral news in gene therapy (24-30 July): A successful week for hemophilia GT Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
August 01, 2016 Eyegate Pharmaceuticals, Inc. EYEG: Encouraging Data From Cataract Surgery Study. Therapeutics, Devices & Diagnostics EYEG Buy Keay Nakae, CFA Register
August 03, 2016 CaesarStone Sdot-Yam Ltd. Impressive margins, but US growth is still slow Manufacturing CSTE Buy Lena Rogovin Register
August 04, 2016 Sunworks, Inc. Initiating Coverage with Buy and $5 Target Price Industrial & Consumer Technology SUNW Buy JAMES McILREE, CFA Register
August 04, 2016 iPass Inc. Unlimited Plan Showing Traction. Raise to Buy Industrial & Consumer Technology IPAS Buy JAMES McILREE, CFA Register
August 04, 2016 ORBCOMM, Inc. ORBCOMM Q2 In line. Guidance Reaffirmed Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
August 04, 2016 Ophthotech Corporation Post 2Q16: On track ahead of 4Q16 Fovista pivotal data (reiterate top pick) Biotechnology and Pharmaceuticals OPHT Buy Gbola Amusa Register
August 04, 2016 BCommunication Ltd. 2Q16 better q-o-q, no div. announced, PT reduced to ILS107 on lower BEZQ price Manufacturing BCOM.IT Neutral Lena Rogovin Register
August 05, 2016 Emergent BioSolutions, Inc. EBS: Anticipating Details Of Anthrax Product Contracts Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
August 05, 2016 ORBCOMM, Inc. Reiterate Buy and $11.50 Target Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
August 07, 2016 Viral news in gene therapy (31 July - 6 August): M&A activity picks up in GT Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
August 08, 2016 The KEYW Holding Corporation Q2 Preview. Maintain Buy and $12 Target Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
August 08, 2016 Dicerna Pharmaceuticals, Inc. Reiterate Neutral: PT to $3.50 on continued shift to preclinical programs Biotechnology and Pharmaceuticals DRNA Neutral Madhu Kumar Register
August 08, 2016 Alnylam Pharmaceuticals, Inc. Reiterate Buy (PT $115) on recent updates to clinical programs Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
August 09, 2016 Ritter Pharmaceuticals, Inc. RTTR: Phase 2b/3 Clinical Trial Remains on Track Therapeutics, Devices & Diagnostics RTTR Buy Keay Nakae, CFA Register
August 09, 2016 IDI, Inc. Solid Q2 Results. idiCORE Ramping. Industrial & Consumer Technology IDI Buy JAMES McILREE, CFA Register
August 09, 2016 Q2 Preview: Sunworks (SUNW), US Geothermal (HTM) Industrial & Consumer Technology JAMES McILREE, CFA Register
August 09, 2016 La Jolla Pharmaceutical Company Post 2Q16: Nearing key LJPC-501 (1Q17) and LJPC-401 (Sep-16) datasets Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa Register
August 09, 2016 Aralez Pharmaceuticals Inc. ARLZ: PDUFA Date For YOSPRALLA Now Just 5 Weeks Away Therapeutics, Devices & Diagnostics Aralez Buy Keay Nakae, CFA Register
August 10, 2016 Novavax, Inc. NVAX: On Deck - Phase 3 Study Results For RSV Vaccine Therapeutics, Devices & Diagnostics NVAX Neutral Keay Nakae, CFA Register
August 10, 2016 BioTime, Inc. BTX: Picture Gets Clearer With Deconsolidation of Asterias Therapeutics, Devices & Diagnostics BTX Buy Keay Nakae, CFA Register
August 10, 2016 The KEYW Holding Corporation Q2 Exceeds Estimates. Maintain Buy and $12 Target Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
August 10, 2016 22nd Century Group, Inc. Q2 Revenue Exceeds Estimates Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
August 10, 2016 U.S. Geothermal Inc. Q2 EBITDA Better than Expected. Outlook Unchanged Industrial & Consumer Technology HTM Neutral JAMES McILREE, CFA Register
August 10, 2016 Sunworks, Inc. Sunworks Crushes Estimates. Guidance Increased Industrial & Consumer Technology SUNW Buy JAMES McILREE, CFA Register
August 11, 2016 Alliqua Inc. ALQA: Resetting Expectations Without Sorbion Therapeutics, Devices & Diagnostics ALQA Buy Keay Nakae, CFA Register
August 11, 2016 Amicus Therapeutics, Inc. Positive: NEJM FACETS publication neutralizes an oft-repeated investor concern Biotechnology and Pharmaceuticals FOLD Buy Gbola Amusa Register
August 11, 2016 Eyegate Pharmaceuticals, Inc. EYEG: Focus Remains on Clinical Studies Therapeutics, Devices & Diagnostics EYEG Buy Keay Nakae, CFA Register
August 11, 2016 Sunworks, Inc. Q2 Beat and Raise Industrial & Consumer Technology SUNW Buy JAMES McILREE, CFA Register
August 11, 2016 22nd Century Group, Inc. Q2 Review. Changes to Model Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
August 11, 2016 Profire Energy Inc. Profire Q2 Results Industrial & Consumer Technology PFIE Neutral JAMES McILREE, CFA Register
August 12, 2016 Medical Transcription Billing, Corp. MTBC: Positive Trends in Cost Reduction Continue in Q2 Therapeutics, Devices & Diagnostics MTBC Buy Keay Nakae, CFA Register
August 12, 2016 REGENXBIO Inc. 10 reasons RGNX is our top pick in vector gene therapy Biotechnology and Pharmaceuticals RGNX Buy Gbola Amusa, MD, CFA Register
August 12, 2016 AveXis, Inc. The AVXS-101 breakthrough story continues to break through Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
August 12, 2016 Opexa Therapeutics, Inc. OPXA: Next Up-Phase 2b SPMS Top Line Results Therapeutics, Devices & Diagnostics OPXA Buy Keay Nakae, CFA Register
August 14, 2016 Viral news in gene therapy (7-13 August): RGNX is our top pick in vector GT Biotechnology and Pharmaceuticals Buy Gbola Amusa, MD, CFA Register
August 15, 2016 Frutarom Industries Ltd Strong 2Q16 results, PT upgrade to ILS199 on higher sector multiples Manufacturing FRUT.IT Neutral Lena Rogovin Register
August 15, 2016 Vuzix Corp. Vuzi Q2 Results Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
August 16, 2016 Asterias Biotherapeutics, Inc. AST: Cervical Spine Study Moves Forward to 3rd Patient Cohort Therapeutics, Devices & Diagnostics AST Buy Keay Nakae, CFA Register
August 16, 2016 Genius Brands International, Inc. Q2 Results. Llama Llama and SpacePOP Key to Success Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
August 16, 2016 Ituran Location and Control Ltd Strong 2Q16 despite lower net adds; PT higher on growth visibility in Brazil Manufacturing ITRN Buy Lena Rogovin Register
August 16, 2016 Genius Brands International, Inc. Q2 Results. Llama Llama and SpacePOP Key to Success Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
August 17, 2016 Fox Wizel Ltd Strong margins support our FY forecast, DCF PT upgrade on lower net debt Manufacturing FOX.IT Buy Lena Rogovin Register
August 21, 2016 Viral news in gene therapy (14-20 August): CRISPR-Cas9 in blood disorders Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
August 22, 2016 Gazit Globe 2Q16 preview and subsidiaries update Manufacturing GZT.IT Buy Lena Rogovin Register
August 23, 2016 Caladrius Biosciences, Inc. CLBS: Enhancing Cell Therapy Value Chain Therapeutics, Devices & Diagnostics CLBS Buy Keay Nakae, CFA Register
August 23, 2016 Check-Cap Ltd. CHEK: Good Progress With Engineering Issues Therapeutics, Devices & Diagnostics CHEK Buy Keay Nakae, CFA Register
August 23, 2016 Gazit Globe 2Q16: NOI in-line, FFO below, P&L improvements on GZT level Manufacturing GZT.IT Buy Lena Rogovin Register
August 23, 2016 Azrieli Group 2Q16 preview Manufacturing AZRG IT Neutral Lena Rogovin Register
August 24, 2016 Nearmap Ltd. Fiscal Second Half Results Exceed Expectations Industrial & Consumer Technology NEA.AX Buy JAMES McILREE, CFA Register
August 25, 2016 Mesoblast Limited MESO: Waiting For Interim Results From Phase 3 Clinical Trials Therapeutics, Devices & Diagnostics MESO Neutral Keay Nakae, CFA Register
August 25, 2016 Azrieli Group 2Q16 results in line; PT upgrade to ILS171 on NOI outlook Manufacturing AZRG IT Neutral Lena Rogovin Register
August 28, 2016 Viral news in gene therapy: Let there be light for CRISPR-Cas9 genome editing Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
August 29, 2016 Axovant Sciences Ltd. Sell (PT$8): Consensus too high, and AXON partner Qaam has open IP questions Biotechnology and Pharmaceuticals AXON Sell Gbola Amusa, MD, CFA Register
August 31, 2016 Rami Levy Shivuk Hashikma 2Q16: Same store revenue declines, but margins are strong Manufacturing RMLI IT Buy Lena Rogovin Register
September 01, 2016 Iridium Communications Inc. SpaceX Explosion Likely to Cause Some Delay to Iridium Launch Industrial & Consumer Technology IRDM Neutral JAMES McILREE, CFA Register
September 02, 2016 Covata Limited Initiate Coverage of Covata with Buy and $A0.23 Price Target Industrial & Consumer Technology CVT:AU Buy JAMES McILREE, CFA Register
September 04, 2016 Viral news in gene therapy: Novartis makes a bold move in ex vivo GT in I-O Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
September 05, 2016 Alony-Hetz Properties & Investments Ltd. 2Q16 update: PT up on lower discount, but further upside is mostly long term Manufacturing ALHE.IT Buy Lena Rogovin Register
September 06, 2016 Arrowhead Pharmaceuticals, Inc. Positive: ARC-AAT phase II trial helps ARWR keep pace in AAT liver disease Biotechnology and Pharmaceuticals ARWR Buy Madhu Kumar Register
September 06, 2016 Positive: Another early-stage gene therapy acquisition (AGN buys RetroSense) Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
September 08, 2016 La Jolla Pharmaceutical Company Positive: Speedy movement of LJPC-401 into pivotal trials Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
September 09, 2016 Achillion Pharmaceuticals, Inc. Mixed phase IIa results: Safety risk vs early/incremental efficacy in HCV Biotechnology and Pharmaceuticals ACHN Sell Madhu Kumar Register
September 12, 2016 Viral news in gene therapy: A second early-stage GT acquisition in 5 weeks Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
September 12, 2016 Sunworks, Inc. Expect Strong Results this year and next, with upside to estimates. Industrial & Consumer Technology SUNW Buy JAMES McILREE, CFA Register
September 15, 2016 CaesarStone Sdot-Yam Ltd. Tene PE Fund buys 3.1% in CSTE from Kibbutz Sdot Yam for $43.5 mn, positive Manufacturing CSTE Buy Lena Rogovin Register
September 16, 2016 Aralez Pharmaceuticals Inc. ARLZ: Third Time's a Charm Therapeutics, Devices & Diagnostics Aralez Buy Keay Nakae, CFA Register
September 18, 2016 Viral news in gene therapy: AAV-based GT up 10.8%, despite AGTC setbacks Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
September 18, 2016 Viral news in gene therapy: AAV-based GT up 10.8%, despite AGTC's setbacks Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
September 19, 2016 The KEYW Holding Corporation KEYW Part of Large Geospatial Contract Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
September 19, 2016 Novartis AG Initiate Buy (PT$95): Eyeing returns from wet AMD and business sustainability Biotechnology and Pharmaceuticals NVS Buy Gbola Amusa, MD, CFA Register
September 20, 2016 Novavax, Inc. NVAX: More Details Needed Post Phase 3 Trial Failure Therapeutics, Devices & Diagnostics NVAX Neutral Keay Nakae, CFA Register
September 20, 2016 BCommunication Ltd. Bond refinancing leads to cost savings, upgrade to BUY on higher upside Manufacturing BCOM.IT Buy Lena Rogovin Register
September 22, 2016 DigitalGlobe Inc. Global EGD Renewed Industrial & Consumer Technology DGI Neutral JAMES McILREE, CFA Register
September 22, 2016 Axovant Sciences Ltd. Reiterate Sell: Lundbeck and Pfizer recent 5-HT6 failures reinforce AXON risks Biotechnology and Pharmaceuticals AXON Sell Gbola Amusa, MD, CFA Register
September 23, 2016 Achillion Pharmaceuticals, Inc. PT to $5 (+25%): 6-week success in phase IIa positive signal in HCV therapy Biotechnology and Pharmaceuticals ACHN Sell Madhu Kumar Register
September 25, 2016 Viral news in gene therapy: Uh oh, gene editing of human embryos begins? Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
September 26, 2016 Delta Galil Industries Ltd. Diversified exposure to growing segments of changing global apparel industry Manufacturing DELTY Buy Lena Rogovin Register
September 26, 2016 Genius Brands International, Inc. SpacePOP Update Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
September 27, 2016 Cogint, Inc. Name Change to Cogint Industrial & Consumer Technology COGT Buy JAMES McILREE, CFA Register
September 28, 2016 22nd Century Group, Inc. Surveys Increase Likelihood of X-22 Funding. 2.25 M Warrants Expire Thursday. Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
September 29, 2016 Vuzix Corp. M300 DVT Shipments Begin. iWear Rework Program Lags Expectations Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
September 29, 2016 Arrowhead Pharmaceuticals, Inc. Positive: AMGN partnership validates broader potential for RNAi in CV space Biotechnology and Pharmaceuticals ARWR Buy Madhu Kumar Register
September 30, 2016 Arbutus Biopharma Corporation Reiterate Sell: ARB-1467 phase IIa failure reinforces inferiority in HBV RNAi Biotechnology and Pharmaceuticals ABUS Sell Madhu Kumar Register
September 30, 2016 Regeneron Pharmaceuticals, Inc. Thesis confirmed: Rinucumab add-on shows no benefit over Eylea alone Biotechnology and Pharmaceuticals REGN Sell Gbola Amusa, MD, CFA Register
September 30, 2016 Emergent BioSolutions, Inc. EBS: Company Secures BARDA Contract For Next Generation Anthrax Vaccine Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
October 02, 2016 Viral news in gene therapy: A hearty RNAi deal, as RNAi beat stops in cancers Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
October 06, 2016 Alnylam Pharmaceuticals, Inc. ALNY (Buy): PT to $77 (-33%) on revusiran phase III halt, TTR-FAC uncertainty Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
October 06, 2016 The Medicines Company MDCO (Buy): PT to $57.50 (-12%) on RNAi platform risk assessment Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
October 09, 2016 Viral news in gene therapy: Bullish on RNAi, despite revusiran; AVXS updates Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
October 10, 2016 Novartis AG Negative (PT to $92, -3%): LEE011 shows an uncompetitive liver profile Biotechnology and Pharmaceuticals NVS Buy Gbola Amusa, MD, CFA Register
October 11, 2016 Aralez Pharmaceuticals Inc. ARLZ: Updating Estimates to Reflect Recent Licensing of Toprol-XL Therapeutics, Devices & Diagnostics Aralez Buy Keay Nakae, CFA Register
October 11, 2016 Medical Transcription Billing, Corp. MTBC: Updating Estimates to Reflect Recent Acquisition Therapeutics, Devices & Diagnostics MTBC Buy Keay Nakae, CFA Register
October 11, 2016 DigitalGlobe Inc. Acquisition of Radiant Group Industrial & Consumer Technology DGI Neutral JAMES McILREE, CFA Register
October 12, 2016 Inventergy: Capital Raise, Fortress LOI, Inventergy Innovations Industrial & Consumer Technology JAMES McILREE, CFA Register
October 13, 2016 Esperion Therapeutics, Inc. Bempedoic acid is increasingly in "no man's land" Biotechnology and Pharmaceuticals ESPR Neutral Gbola Amusa, MD, CFA Register
October 14, 2016 Arbutus Biopharma Corporation Upgrade to Neutral on 37%-52% underperfomance vs ARWR and S&P Biotech Index Biotechnology and Pharmaceuticals ABUS Neutral Madhu Kumar Register
October 17, 2016 22nd Century Group, Inc. Ample Cash to Pursue Multiple Large Market Opportunities Industrial Equipment & Services XXII Buy JAMES McILREE, CFA Register
October 17, 2016 Viral news in gene therapy: AVXS-101 patients are walking Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
October 18, 2016 Cogint, Inc. Cogint Pre-Announces Q3 Revenue Far Ahead of Expectations Industrial Equipment & Services COGT Buy JAMES McILREE, CFA Register
October 23, 2016 Viral news in gene therapy: MDCO delivers on PCSK9si; CRSP IPO downsized Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
October 24, 2016 DigitalGlobe Inc. DigitalGlobe Q3 Scheduled to be Released Tuesday Industrial Equipment & Services DGI Neutral JAMES McILREE, CFA Register
October 25, 2016 Clovis Oncology, Inc. Initiate Sell (PT$15) on rucaparib's poor risk-benefit profile (Feb-17 PDUFA) Biotechnology and Pharmaceuticals CLVS Sell Madhu Kumar Register
October 25, 2016 Ritter Pharmaceuticals, Inc. RTTR: Key Data Readout Now Expected in Q1 Therapeutics, Devices & Diagnostics RTTR Buy Keay Nakae, CFA Register
October 26, 2016 DigitalGlobe Inc. Q3 Better than Expected. Guidance Raised Industrial & Consumer Technology DGI Neutral JAMES McILREE, CFA Register
October 26, 2016 Gene therapy: Closing our sub-sector (AAV vs. gene editing) pair trade Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
October 27, 2016 Gazit Globe EQY/CTY 3Q16 review and GZT financing update Manufacturing GZT.IT Buy Lena Rogovin Register
October 28, 2016 Astrotech Corporation Initiating Coverage with Buy Recommendation and $5 Target Price Industrial & Consumer Technology ASTC Buy JAMES McILREE, CFA Register
October 28, 2016 ProQR Therapeutics NV Reiterate Neutral: QR-010 NPD results suggest modest effect in delF508 CF Biotechnology and Pharmaceuticals PRQR Neutral Madhu Kumar Register
October 28, 2016 ALXN1210 pivotal trials in PNH/aHUS suggest delays for complement competitors Biotechnology and Pharmaceuticals Madhu Kumar Register
October 28, 2016 Iridium Communications Inc. Q3 EBITDA Exceeds Estimates. Lower 2017 estimates on NEXT launch delay Industrial & Consumer Technology IRDM Neutral JAMES McILREE, CFA Register
October 28, 2016 Alliqua Inc. ALQA: Q3 2016 Earnings Preview Therapeutics, Devices & Diagnostics ALQA Buy Keay Nakae, CFA Register
October 28, 2016 Opexa Therapeutics, Inc. OPXA: Phase 2b Study Fails to Hit Endpoint Therapeutics, Devices & Diagnostics OPXA Neutral Keay Nakae, CFA Register
October 30, 2016 CaesarStone Sdot-Yam Ltd. 3Q16 preview: Focus on the US growth Manufacturing CSTE Buy Lena Rogovin Register
October 30, 2016 Viral news in gene therapy: PRQR produces modest results in delF508 CF Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
October 31, 2016 Ophthotech Corporation Positive: Phase IIb Fovista results published in Ophthalmology Biotechnology and Pharmaceuticals OPHT Buy Gbola Amusa, MD, CFA Register
November 01, 2016 KVH Industries Inc. Q3 Preview. Counting on Tacnav for the year. Industrial & Consumer Technology KVHI Neutral JAMES McILREE, CFA Register
November 01, 2016 ORBCOMM, Inc. Q3 Preview. Still Bullish on Outlook Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
November 01, 2016 The KEYW Holding Corporation Q3 Preview. Remain positive on expanding customer base Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
November 01, 2016 The Medicines Company MDCO: PT to $65; failure of bococizumab increases chance of MDCO acquisition Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
November 02, 2016 Cogint, Inc. Q3 Preview. Looking for improved margins in Q4 Industrial & Consumer Technology COGT Buy JAMES McILREE, CFA Register
November 02, 2016 iPass Inc. Q3 Preview. Global WiFi Network Continues to Grow Industrial & Consumer Technology IPAS Buy JAMES McILREE, CFA Register
November 02, 2016 Emergent BioSolutions, Inc. EBS: Q3 2016 Earnings Preview Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
November 02, 2016 AveXis, Inc. PT to $85 (+31%): Single-arm pivotal study ahead; filing on phase I possible Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
November 02, 2016 ORBCOMM, Inc. Q3 Hardware Sales Miss Expectations. Still Expect Strong Growth Next Year. Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
November 03, 2016 KVH Industries Inc. TACNAV Push to the Right Industrial & Consumer Technology KVHI Neutral JAMES McILREE, CFA Register
November 03, 2016 The KEYW Holding Corporation Q3 Shortfall. New Awards Suggest Robust Outlook Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
November 03, 2016 Achillion Pharmaceuticals, Inc. Reiterate Sell: ACH-4471 liver signals and developmental delays pose risks Biotechnology and Pharmaceuticals ACHN Sell Madhu Kumar Register
November 04, 2016 Achillion Pharmaceuticals, Inc. Upgrade to Neutral on 47% underperfomance vs S&P Biotech Index Biotechnology and Pharmaceuticals ACHN Neutral Madhu Kumar Register
November 04, 2016 Eyegate Pharmaceuticals, Inc. EYEG: Expecting Additional Clinical Data in Q4 Therapeutics, Devices & Diagnostics EYEG Buy Keay Nakae, CFA Register
November 04, 2016 BioTime, Inc. BTX: Continued Progress With Clinical Initiatives Therapeutics, Devices & Diagnostics BTX Buy Keay Nakae, CFA Register
November 04, 2016 Cogint, Inc. Positioned for Strong Revenue Growth and Margin Expansion Industrial & Consumer Technology COGT Buy JAMES McILREE, CFA Register
November 06, 2016 CaesarStone Sdot-Yam Ltd. PT downgrade to $39 on weak US performance and lower guidance Manufacturing CSTE Buy Lena Rogovin Register
November 07, 2016 Alliqua Inc. ALQA: Focus Shifts to Completion of Soluble Systems Acquisition in Q1 Therapeutics, Devices & Diagnostics ALQA Buy Keay Nakae, CFA Register
November 07, 2016 Viral news in gene therapy: AVXS to file on phase I data? Plus, ASH is ahead Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
November 07, 2016 Regeneron Pharmaceuticals, Inc. PT to $300: Since when is a results call not a forum to discuss drug pricing? Biotechnology and Pharmaceuticals REGN Sell Gbola Amusa, MD, CFA Register
November 07, 2016 Spark Therapeutics, Inc. ONCE (Neutral): PT to $47.50 (-14%); we see better value elsewhere in AAV GT Biotechnology and Pharmaceuticals ONCE Neutral Gbola Amusa, MD, CFA Register
November 07, 2016 Aralez Pharmaceuticals Inc. ARLZ: Focus Now Shifts to Execution Therapeutics, Devices & Diagnostics Aralez Buy Keay Nakae, CFA Register
November 08, 2016 The clot thickens in hemophilia: Growth to accelerate on disruptive therapies Biotechnology and Pharmaceuticals Madhu Kumar Register
November 08, 2016 Regeneron Pharmaceuticals, Inc. Since when is a results call not the forum to discuss drug pricing? Biotechnology and Pharmaceuticals REGN Sell Gbola Amusa, MD, CFA Register
November 08, 2016 Emergent BioSolutions, Inc. EBS: Waiting For Final Details of CDC Follow-on Contract for BioThrax Healthcare EBS Buy Keay Nakae, CFA Register
November 08, 2016 Caladrius Biosciences, Inc. CLBS: Revenue Up, Expenses Down, Again Healthcare CLBS Buy Keay Nakae, CFA Register
November 08, 2016 VistaGen Therapeutics Buy (PT$30): Phase IIa results in 1H17 to expose a blockbuster opportunity? Biotechnology and Pharmaceuticals VTGN Buy Gbola Amusa, MD, CFA Register
November 08, 2016 Genius Brands International, Inc. Expanding Investor Base. Monetizing SpacePOP. Industrial Equipment & Services GNUS Buy JAMES McILREE, CFA Register
November 08, 2016 Ritter Pharmaceuticals, Inc. RTTR: Focus Shifts to Topline Results of Phase 2b/3 Clinical Study in Q1 Therapeutics, Devices & Diagnostics RTTR Buy Keay Nakae, CFA Register
November 09, 2016 Sunworks, Inc. Q3 Preview. Positioned for Superior Growth Industrial Equipment & Services SUNW Buy JAMES McILREE, CFA Register
November 09, 2016 NICE-Systems Ltd. 3Q16 preview: We expect another strong quarter Manufacturing NICE Buy Lena Rogovin Register
November 10, 2016 Novavax, Inc. NVAX: Company Announces Corporate Restructuring Plan Therapeutics, Devices & Diagnostics NVAX Neutral Keay Nakae, CFA Register
November 10, 2016 Arrowhead Pharmaceuticals, Inc. PT to $8 (-20%) on ARC-520 clinical hold: The Bull Case and the Bear Case Biotechnology and Pharmaceuticals ARWR Buy Madhu Kumar Register
November 10, 2016 U.S. Geothermal Inc. Q3 as Expected. Some Expansion Projects Pushed to the Right Industrial Equipment & Services HTM Neutral JAMES McILREE, CFA Register
November 10, 2016 Sunworks, Inc. Significant Q3 Shortfall Industrial & Consumer Technology SUNW Buy JAMES McILREE, CFA Register
November 11, 2016 Medical Transcription Billing, Corp. MTBC: Acquisition Should Drive Revenue Growth in Future Quarters Therapeutics, Devices & Diagnostics MTBC Buy Keay Nakae, CFA Register
November 11, 2016 Bristol-Myers Squibb's Daklinza faces particular FDA boxed warning HBV risk Biotechnology and Pharmaceuticals Madhu Kumar Register
November 13, 2016 Viral news in gene therapy: ARWR receives clinical hold & AASLD/AHA previews Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
November 14, 2016 Liver Meeting: AASLD update; days 1, 2, and 3 (BMY, ARWR, ACHN, RGLS, GILD) Biotechnology and Pharmaceuticals Madhu Kumar Register
November 14, 2016 NICE-Systems Ltd. 3Q16: strong profitability, FY guidance upgraded on InContact contribution Manufacturing NICE Buy Lena Rogovin Register
November 14, 2016 Alnylam Pharmaceuticals, Inc. Positive: Sanofi fitusiran opt-in reinforces validating partnership for ALNY Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
November 15, 2016 Liver Meeting: AASLD update; day 4 (ABUS, ASMB, JNJ, GILD, ROG.VX) Biotechnology and Pharmaceuticals Madhu Kumar Register
November 15, 2016 Asterias Biotherapeutics, Inc. AST: Pace of Enrollment in Spinal Cord Injury Study Steps Up. Therapeutics, Devices & Diagnostics AST Buy Keay Nakae, CFA Register
November 15, 2016 Mesoblast Limited MESO: GvHD Clinical Trial Passes Futility Test Therapeutics, Devices & Diagnostics MESO Neutral Keay Nakae, CFA Register
November 15, 2016 Gazit Globe EQY merges with Regency Centers (REG), positive for GZT Manufacturing GZT.IT Buy Lena Rogovin Register
November 15, 2016 Vuzix Corp. M300 Volume Production Begins Soon: Drives Hockey stick in sales Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
November 15, 2016 uniQure N.V. QURE (Buy): PT to $12 (-40%) on drug discontinuations after a strategic review Biotechnology and Pharmaceuticals QURE Buy Gbola Amusa, MD, CFA Register
November 15, 2016 The Medicines Company MDCO (Buy): Inclisiran lowers LDL 51-57%, and is going "aggressively" into PIII Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
November 16, 2016 Teladoc, Inc. Initiate Buy PT $24: We see strong demand for telehealth in 2017 Digital Health TDOC Buy Steven Wardell Register
November 16, 2016 Catasys Inc. CATS: Company Reports Q3 2017 Results Therapeutics, Devices & Diagnostics CATS Buy Keay Nakae, CFA Register
November 16, 2016 AHA 2016: GLAGOV increases odds of PCSK9 inhibitor breakthroughs Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
November 17, 2016 Ituran Location and Control Ltd 3Q16: Strong revenue growth in Israel and Brazil, but could slow down in Q4 Manufacturing ITRN Buy Lena Rogovin Register
November 17, 2016 Check-Cap Ltd. CHEK: Moving Towards Commencement of CE Mark Efficacy Study Healthcare CHEK Buy Keay Nakae, CFA Register
November 17, 2016 Vuzix Corp. Intel Steps Back from Vuzix Relationship, Opening Door for Others Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
November 17, 2016 Delta Galil Industries Ltd. 3Q16 uneventful for core business, CBC integration on track, more growth ahead Manufacturing DELTY Buy Lena Rogovin Register
November 21, 2016 Viral news in gene therapy: MDCO and ALNY to move inclisiran into phase III Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
November 21, 2016 Frutarom Industries Ltd 3Q16 preview Manufacturing FRUT.IT Neutral Lena Rogovin Register
November 21, 2016 Azrieli Group 3Q16 preview Manufacturing AZRG IT Neutral Lena Rogovin Register
November 22, 2016 Frutarom Industries Ltd In-line 3Q16, new catalysts needed to justify valuations Manufacturing FRUT.IT Neutral Lena Rogovin Register
November 22, 2016 Gazit Globe GZT 3Q16 preview Manufacturing GZT.IT Buy Lena Rogovin Register
November 23, 2016 Azrieli Group Strong 3Q16 and further progress in pre-lease rates Manufacturing AZRG IT Neutral Lena Rogovin Register
November 23, 2016 Gazit Globe 3Q16 results in-line with expectations Manufacturing GZT.IT Buy Lena Rogovin Register
November 23, 2016 Genius Brands International, Inc. SpacePop in Toys R Us Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
November 23, 2016 Fox Wizel Ltd Solid 3Q16 despite seasonality, net affected by negative hedging result Manufacturing FOX.IT Buy Lena Rogovin Register
November 24, 2016 BCommunication Ltd. 3Q16: loss on early bond redemption costs, high discount to target NAV Manufacturing BCOM.IT Buy Lena Rogovin Register
November 28, 2016 Viral news in gene therapy: Juno reports a 3rd clinical hold; ASH is here Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
November 29, 2016 There will be blood: ASH 2016 preview (ALNY, ALXN, ONCE, QURE) Biotechnology and Pharmaceuticals Madhu Kumar Register
November 29, 2016 Rami Levy Shivuk Hashikma Strong 3Q16 results support our positive outlook Manufacturing RMLI IT Buy Lena Rogovin Register
November 29, 2016 Amicus Therapeutics, Inc. PT $16 (+6%): US Galafold POS 55%, from 40%; US launch 2H20E, from 2H18E Biotechnology and Pharmaceuticals FOLD Buy Gbola Amusa, MD, CFA Register
November 29, 2016 Vascular Biogenics Ltd. VB-111 top-line data show preliminary evidence of OS benefit in thyroid cancer Biotechnology and Pharmaceuticals VBLT Buy Gbola Amusa, MD, CFA Register
November 30, 2016 WageWorks, Inc. Initiate Buy PT $86: Helping Employees Become Healthcare Consumers in 2017 Digital Health WAGE Buy Steven Wardell Register
November 30, 2016 Arrowhead Pharmaceuticals, Inc. Downgrade to Neutral (PT to $2; -75%) on EX-1 RNAi program discontinuations Biotechnology and Pharmaceuticals ARWR Neutral Madhu Kumar Register
November 30, 2016 Arbutus Biopharma Corporation Upgrade to Buy (PT to $4; +25%) on ARWR hepatitis B program discontinuations Biotechnology and Pharmaceuticals ABUS Buy Madhu Kumar Register
November 30, 2016 Alnylam Pharmaceuticals, Inc. PT to $89 (+18%) on ARWR EX-1 RNAi program discontinuations Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
December 02, 2016 Iridium Communications Inc. Iridium NEXT First Launch Could be This Month Industrial & Consumer Technology IRDM Neutral JAMES McILREE, CFA Register
December 04, 2016 ASH 2016: QURE might lead in hemB timing, but ONCE has better efficacy Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
December 04, 2016 Alnylam Pharmaceuticals, Inc. Positive: ASH data reinforces potential for RNAi across hemophilia and AIP Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar Register
December 04, 2016 Viral news in gene therapy: ARWR discontinues EX-1 programs Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
December 05, 2016 Blood will have blood: ASH Days 1 and 2 (ROG.VX, ALNY, ONCE, QURE, ALXN) Biotechnology and Pharmaceuticals Madhu Kumar Register
December 05, 2016 Vuzix Corp. Heading into CES with a Full Balance Sheet and Broad Product Line Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
December 06, 2016 Eyegate Pharmaceuticals, Inc. EYEG: More Encouraging Data From Cataract Surgery Study. Therapeutics, Devices & Diagnostics EYEG Buy Keay Nakae, CFA Register
December 07, 2016 Regulus Therapeutics, Inc. PT to $5 (-58%): New targets are promising, but clinical delays increase risk Biotechnology and Pharmaceuticals RGLS Buy Madhu Kumar, PhD Register
December 07, 2016 Alony-Hetz Properties & Investments Ltd. ALHE 3Q16 update - our positive view unchanged, but short-term catalysts needed Manufacturing ALHE.IT Buy Lena Rogovin Register
December 08, 2016 Voyager Therapeutics, Inc. VY-AADC01: Are phase Ib results a placebo effect? Biotechnology and Pharmaceuticals VYGR Neutral Gbola Amusa, MD, CFA Register
December 09, 2016 Emergent BioSolutions, Inc. EBS: Follow-on Contract For BioThrax With CDC Completed Healthcare EBS Buy Keay Nakae, CFA Register
December 11, 2016 Viral news in gene therapy: ASH takeaways, plus caution on new VYGR data Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
December 12, 2016 Ophthotech Corporation Downgrade to Neutral (PT$15): Fovista fails in phase III trials in wet AMD Biotechnology and Pharmaceuticals OPHT Neutral Gbola Amusa, MD, CFA Register
December 12, 2016 Regeneron Pharmaceuticals, Inc. Upgrade to Neutral (PT$350) on recent underperformance and Fovista's failure Biotechnology and Pharmaceuticals REGN Neutral Gbola Amusa, MD, CFA Register
December 12, 2016 La Jolla Pharmaceutical Company LJPC (Buy): PT to $75 from $80 on R&D expense build from pipeline advancement Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
December 12, 2016 Esperion Therapeutics, Inc. ESPR (Neutral): PT reduced to $10 from $12.50, after post-3Q16 model updates Biotechnology and Pharmaceuticals ESPR Neutral Gbola Amusa, MD, CFA Register
December 13, 2016 HealthEquity, Inc. Initiate Buy PT $50: Well Positioned for HSA Growth Digital Health HQY Buy Steven Wardell Register
December 13, 2016 Arbutus Biopharma Corporation Downgrade to Neutral (PT $3): Liver safety risk overwhelms promising efficacy Biotechnology and Pharmaceuticals ABUS Neutral Madhu Kumar, PhD Register
December 15, 2016 Profire Energy Inc. Upgrade to Buy with $2 Price Target Industrial & Consumer Technology PFIE Buy JAMES McILREE, CFA Register
December 16, 2016 iPass Inc. Move to Unlimited Offset by Enterprise Weakness. Lower to Neutral Industrial Equipment & Services IPAS Neutral JAMES McILREE, CFA Register
December 18, 2016 ACE910 preview: TMA risk could outweigh efficacy (ROG.VX, NVO, SHPG, ALNY) Biotechnology and Pharmaceuticals Madhu Kumar, PhD Register
December 18, 2016 Alnylam Pharmaceuticals, Inc. PT to $69 (-22%) post late-16 updates, but we remain bullish for pivotal 2017 Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar, PhD Register
December 18, 2016 Viral news in gene therapy: ABUS shows safety risk; ALNY guides 2017 plans Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
December 19, 2016 NICE-Systems Ltd. Investor day key takeaways Food Retail NICE Buy Lena Rogovin Register
December 19, 2016 Globalstar Inc. Rally on Circulation of Revised Proposal Industrial Equipment & Services GSAT Neutral JAMES McILREE, CFA Register
December 20, 2016 Clovis Oncology, Inc. Upgrade to Neutral (PT $36): Rubraca approval balanced by limited upside Biotechnology and Pharmaceuticals CLVS Neutral Madhu Kumar, PhD Register
December 22, 2016 AveXis, Inc. AVXS-101 SMA type 1 patients are indeed type 1; important trials start in 2017 Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
December 22, 2016 ACE910 achieves efficacy in hemophilia inhibitor group, with uncertain safety Biotechnology and Pharmaceuticals Madhu Kumar, PhD Register
December 27, 2016 Globalstar Inc. FCC Approves TLPS Industrial & Consumer Technology GSAT Neutral JAMES McILREE, CFA Register
December 27, 2016 Covata Limited New CEO Announced Industrial & Consumer Technology CVT:AU Buy JAMES McILREE, CFA Register
December 27, 2016 AveXis, Inc. The Spinraza label hints at why AVXS-101 should be the superior product Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
December 27, 2016 Fortress Deal Positions Inventergy for Growth Industrial & Consumer Technology JAMES McILREE, CFA Register
January 01, 2017 Viral news in gene therapy: AveXis confirms manufacturing and SMA 1 diagnoses Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
January 03, 2017 Emergent BioSolutions, Inc. EBS: Our Top Pick to Start 2017 Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
January 03, 2017 Emergent BioSolutions, Inc. EBS: Our Sector Top Pick to Start 2017 Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
January 04, 2017 Year Behind, Year Ahead Industrial & Consumer Technology JAMES McILREE, CFA Register
January 04, 2017 Regeneron Pharmaceuticals, Inc. Rejected judgment as a matter of law may signal Praluent decision (or not) Biotechnology and Pharmaceuticals REGN Neutral Gbola Amusa, MD, CFA Register
January 05, 2017 22nd Century Group, Inc. FDA responds to MRTP Application Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
January 05, 2017 Viral news in gene therapy: 2016 in review - AAV GT outperforms GT and biotech Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
January 06, 2017 Benefitfocus, Inc. BNFT: Initiate Buy PT $36, Bringing Benefits To the Cloud Digital Health BNFT Buy Steven Wardell Register
January 06, 2017 Regeneron Pharmaceuticals, Inc. Thesis confirmed: Permanent injunction granted against Praluent Biotechnology and Pharmaceuticals REGN Neutral Gbola Amusa, MD, CFA Register
January 06, 2017 The Medicines Company MDCO: A top pick for 2017 (reiterate Buy) Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
January 09, 2017 Teladoc, Inc. TDOC Guides to $182.5m Revenue in '07, 2% below Street Digital Health TDOC Buy Steven Wardell Register
January 09, 2017 The KEYW Holding Corporation Expect Strong Performance in 2017 Industrial Equipment & Services KEYW Buy JAMES McILREE, CFA Register
January 09, 2017 Globalstar Inc. Globalstar Previews a Small Cell Service Industrial Equipment & Services GSAT Neutral JAMES McILREE, CFA Register
January 09, 2017 Alnylam Pharmaceuticals, Inc. PT to $97 (+41%) on APOLLO landing the phase III moonshot in TTR-FAP Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar, PhD Register
January 09, 2017 Chardan Israel 2017 Outlook: Real Estate, RMLI, NICE, CSTE Manufacturing Lena Rogovin Register
January 09, 2017 Viral news in gene therapy: Multiple IND filings show GT pipelines expanding Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
January 10, 2017 Regeneron Pharmaceuticals, Inc. Praluent catalyst alert: Injunction appeal decision could come by April 2017 Biotechnology and Pharmaceuticals REGN Neutral Gbola Amusa, MD, CFA Register
January 11, 2017 NICE-Systems Ltd. PT up to $76 on InContact and forecast period update; $150 mn buyback announced Israeli Equities NICE Buy Lena Rogovin Register
January 13, 2017 Strauss Group Ltd. More global opportunities ahead, Sabra recovery is a key near term catalyst Israeli Equities STRS Neutral Lena Rogovin Register
January 17, 2017 Spinraza label suggests platform platelet risk for antisense oligonucleotides Biotechnology and Pharmaceuticals Madhu Kumar, PhD Register
January 17, 2017 Viral news in gene therapy: Orphan Drug Designations continue to drive GT Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
January 17, 2017 Check-Cap Ltd. CHEK: Company Enrolls First Patient in CE Mark Study Therapeutics, Devices & Diagnostics CHEK Buy Keay Nakae, CFA Register
January 18, 2017 Teladoc, Inc. TDOC Announces Proposed Share Offering Digital Health TDOC Buy Steven Wardell Register
January 22, 2017 Viral news in gene therapy: More ODDs in 2017; urging caution on ABEO (unrated) Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
January 23, 2017 Asterias Biotherapeutics, Inc. AST: Company to Provide SCiStar Update Tomorrow Therapeutics, Devices & Diagnostics AST Buy Keay Nakae, CFA Register
January 23, 2017 U.S. Geothermal Inc. US Geothermal 2017 Guidance Industrial Equipment & Services HTM Neutral JAMES McILREE, CFA Register
January 23, 2017 Limited Spinraza reimbursement suggests risk for broader IONS SMA franchise Biotechnology and Pharmaceuticals Madhu Kumar, PhD Register
January 24, 2017 La Jolla Pharmaceutical Company LJPC (Buy): A top pick for 2017 heading into LJPC-501's pivotal phase III data Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
January 25, 2017 Asterias Biotherapeutics, Inc. AST: Company Reports Encouraging Interim Data From Spinal Cord Injury Study Therapeutics, Devices & Diagnostics AST Buy Keay Nakae, CFA Register
January 25, 2017 2017 Outlook for Digital Health Sub Sectors Digital Health Steven Wardell Register
January 25, 2017 AveXis, Inc. AVXS (Buy): PT to $100, FDA review consistent with our Spinraza safety concerns Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
January 25, 2017 Spinraza FDA review confirms our concerns of antisense platelet class effects Biotechnology and Pharmaceuticals Madhu Kumar, PhD Register
January 30, 2017 Trump Healthcare Reform: Good for HSAs, Mixed for Healthcare IT Digital Health Steven Wardell Register
January 30, 2017 Emergent BioSolutions, Inc. EBS: Key Takeaways From Recent Meetings With Management Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
January 30, 2017 Viral News in Gene Therapy: The RG-101 clinical hold to continue through 2017 Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
January 30, 2017 uniQure N.V. Positive: AMT-060 receives Breakthrough Therapy Designation in hemophilia B Biotechnology and Pharmaceuticals QURE Buy Gbola Amusa, MD, CFA Register
January 30, 2017 Benefitfocus, Inc. BNFT-BUY housekeeping update to introduce CPS value $1.71 Digital Health BNFT Buy Steven Wardell Register
January 30, 2017 HealthEquity, Inc. HQY-BUY housekeeping update to introduce CPS value $2.79 Digital Health HQY Buy Steven Wardell Register
January 30, 2017 Teladoc, Inc. TDOC-BUY housekeeping update to introduce CPS value $1.39 Digital Health TDOC Buy Steven Wardell Register
January 30, 2017 WageWorks, Inc. WAGE-BUY housekeeping update to introduce CPS value $18.20 Digital Health WAGE Buy Steven Wardell Register
January 31, 2017 Dimension Therapeutics, Inc. Negative: Liver data suggests a noncompetitive profile for DTX101 in hemB Biotechnology and Pharmaceuticals DMTX Neutral Gbola Amusa, MD, CFA Register
February 01, 2017 Social Reality, Inc. Initiating Coverage with Buy and $9 Target Industrial & Consumer Technology SRAX Buy JAMES McILREE, CFA Register
February 01, 2017 The KEYW Holding Corporation Loading the Balance Sheet for M&A Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
February 02, 2017 Frutarom Industries Ltd Raise PT to ILS204 on updated model assumptions; Company exercises PTI option Israeli Equities FRUT.IT Neutral Lena Rogovin Register
February 02, 2017 Alnylam Pharmaceuticals, Inc. Positive: New fitusiran data shows breakthrough bleed mgmt, LT RNAi stability Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar, PhD Register
February 02, 2017 Catasys Inc. CATS: Company Secures Significant New Contract with UnitedHealth Therapeutics, Devices & Diagnostics CATS Buy Keay Nakae, CFA Register
February 02, 2017 Clovis Oncology, Inc. Downgrade to Sell: Weak IP and limited indications suggest over-valuation Biotechnology and Pharmaceuticals CLVS Sell Madhu Kumar, PhD Register
February 02, 2017 The Medicines Company Thesis supported: Positive - Repatha meets primary endpoint in CVOT trials Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
February 05, 2017 Viral News in Gene Therapy: BTDs/PRIMEs continue; DTX101 shows liver signal Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
February 06, 2017 Applied Genetic Technologies Corporation AGTC (Buy): Cash per share updated to $9.04 Biotechnology and Pharmaceuticals AGTC Buy Gbola Amusa, MD, CFA Register
February 06, 2017 CaesarStone Sdot-Yam Ltd. 4Q16 preview: Focus on the US, gross margin and'17E guidance Israeli Equities CSTE Buy Lena Rogovin Register
February 07, 2017 HealthEquity, Inc. HQY Pre-Announces Strong Metrics, Guides In-Line with Street for F2018 Digital Health HQY Buy Steven Wardell Register
February 07, 2017 MYOS: Launch Of New Marketing Initiative On Deck Therapeutics, Devices & Diagnostics Keay Nakae, CFA Register
February 09, 2017 Applied Genetic Technologies Corporation AGTC (Buy): PT to $10 (-33%) on uncertain timing on final phase I/II data Biotechnology and Pharmaceuticals AGTC Buy Gbola Amusa, MD, CFA Register
February 09, 2017 CaesarStone Sdot-Yam Ltd. 4Q16 surprises on the upside, the co to enter new niches/markets in 2017 Israeli Equities CSTE Buy Lena Rogovin Register
February 10, 2017 iPass Inc. Q4 Revenue in Line. Capacity Additions Pressuring Margins in the Short term Industrial & Consumer Technology IPAS Neutral JAMES McILREE, CFA Register
February 13, 2017 HealthEquity, Inc. HQY Sees Strong Demand, Positive Regulatory Environment, Inorganic Changes Digital Health HQY Buy Steven Wardell Register
February 13, 2017 Viral News in Gene Therapy: AVXS to pivotals in EU; GT restores hearing in mice Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
February 14, 2017 NICE-Systems Ltd. 4Q16 preview Israeli Equities NICE Buy Lena Rogovin Register
February 14, 2017 Sage Therapeutics, Inc. SAGE: Upgrade to Neutral (with a [+] bias) on intriguing phase II data in MDD Biotechnology and Pharmaceuticals SAGE Neutral Gbola Amusa, MD, CFA Register
February 14, 2017 Genius Brands International, Inc. Mattel Signs on for Rainbow Rangers. Warrant Exercise Strengthens Balance Sheet Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
February 15, 2017 Nearmap Ltd. Strong Growth Continues Industrial & Consumer Technology NEA.AX Buy JAMES McILREE, CFA Register
February 16, 2017 Ritter Pharmaceuticals, Inc. RTTR: On Deck -Topline Results From Phase 2b/3 Clinical Trial Healthcare RTTR Buy Keay Nakae, CFA Register
February 17, 2017 The Medicines Company MDCO (Buy, PT$65): Immaterial estimate changes on housekeeping update Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
February 19, 2017 Emergent BioSolutions, Inc. EBS: A Sector Top Pick to Start 2017 Healthcare EBS Buy Keay Nakae, CFA Register
February 20, 2017 REGENXBIO Inc. RGNX (Buy, a top pick): An important catalyst emerges for 2017 in wet AMD Biotechnology and Pharmaceuticals RGNX Buy Gbola Amusa, MD, CFA Register
February 20, 2017 Viral News in Gene Therapy: Broad/Editas draws first blood in CRISPR IP fight Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
February 21, 2017 Teladoc, Inc. More Confident in Estimates After Meetings with Management, Investors Digital Health TDOC Buy Steven Wardell Register
February 21, 2017 DigitalGlobe Inc. Takeover Talks Drive Stock Higher Industrial & Consumer Technology DGI Neutral JAMES McILREE, CFA Register
February 21, 2017 NICE-Systems Ltd. Good 4Q16, '17 sales guidance looks conservative, but margins under pressure Israeli Equities NICE Buy Lena Rogovin Register
February 22, 2017 Axovant Sciences Ltd. AXON (Sell): PT to $7.50 (from $8) after post-results housekeeping Biotechnology and Pharmaceuticals AXON Sell Gbola Amusa, MD, CFA Register
February 22, 2017 Spark Therapeutics, Inc. ONCE (Neutral): PT to $55, from $47.50, after modeling SPK-8011 in hemA Biotechnology and Pharmaceuticals ONCE Neutral Gbola Amusa, MD, CFA Register
February 22, 2017 Esperion Therapeutics, Inc. ESPR (Neutral): PT $20 (from $10) on WACC of 16% (from 12.5%) on PIII start Biotechnology and Pharmaceuticals ESPR Neutral Gbola Amusa, MD, CFA Register
February 22, 2017 More Optimistic on HIT Sector and Controversies After HIMSS '17 Digital Health Steven Wardell Register
February 22, 2017 Regeneron Pharmaceuticals, Inc. REGN (Neutral): PT to $350 from $345 on housekeeping updates Biotechnology and Pharmaceuticals REGN Neutral Gbola Amusa, MD, CFA Register
February 23, 2017 OncoCyte Corporation OCX: Initiating Coverage - Proprietary Liquid Biopsy Platform Healthcare OCX Buy Keay Nakae, CFA Register
February 23, 2017 Esperion Therapeutics, Inc. ESPR (Neutral): PT $20 (from $10) on WACC of 12.5% (from 15.5%) on PIII start Biotechnology and Pharmaceuticals ESPR Neutral Gbola Amusa, MD, CFA Register
February 23, 2017 La Jolla Pharmaceutical Company LJPC (Buy): PT to $80 from $75 on model housekeeping post FY16 results Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
February 24, 2017 Emergent BioSolutions, Inc. EBS: Company Updates 2020 Aspirational Goals Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
February 24, 2017 Iridium Communications Inc. Q4 in Line. Aireon Funding Delays Result in Cash Conservation Measures Industrial & Consumer Technology IRDM Neutral JAMES McILREE, CFA Register
February 24, 2017 WageWorks, Inc. Small 4Q miss, guiding in-line for 2017, reiterate Buy, PT $87 Digital Health WAGE Buy Steven Wardell Register
February 24, 2017 Benefitfocus, Inc. More cautious on BNFT as Management discusses issues in 1H17 Digital Health BNFT Buy Steven Wardell Register
February 24, 2017 Globalstar Inc. Raise to Buy with $2.50 Price Target Industrial & Consumer Technology GSAT Buy JAMES McILREE, CFA Register
February 24, 2017 3rd TMA poses ACE910 (ROG.VX) safety concern, risk to SHPG hemophilia franchise Biotechnology and Pharmaceuticals Madhu Kumar, PhD Register
February 26, 2017 Viral News in Gene Therapy: Will the first GT US drug approval be in 2017? Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
February 26, 2017 DigitalGlobe Inc. Agrees to be Acquired by Macdonald Dettwiler Industrial Equipment & Services DGI Neutral JAMES McILREE, CFA Register
February 27, 2017 Delta Galil Industries Ltd. 36% GM helped 4Q16, TP cut to $31, rating to Neutral on low '17 guidance Israeli Equities DELTY Neutral Lena Rogovin Register
February 27, 2017 Eyegate Pharmaceuticals, Inc. EYEG: Company Moving Multiple Programs Forward Healthcare EYEG Buy Keay Nakae, CFA Register
February 28, 2017 Novavax, Inc. NVAX: Waiting For New Clinical Data Healthcare NVAX Neutral Keay Nakae, CFA Register
February 28, 2017 Mesoblast Limited MESO: On Deck-Interim Analysis of Phase 3 CHF Study Healthcare MESO Neutral Keay Nakae, CFA Register
February 28, 2017 ORBCOMM, Inc. ORBCOMM Q4 Shy of Estimates Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
March 01, 2017 Ituran Location and Control Ltd Strong 4Q16, IRT gains momentum in Brazil, BUY maintained Israeli Equities ITRN Buy Lena Rogovin Register
March 01, 2017 Catasys Inc. CATS: Company Reports Q4 2016 Results Healthcare CATS Buy Keay Nakae, CFA Register
March 02, 2017 La Jolla Pharmaceutical Company LJPC (Buy): PT to $90 (+12.5%) on robust LJPC-501 phase III topline results Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
March 02, 2017 Further evidence GT is emerging: ALNY, ONCE receive EMA PRIME designations Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
March 02, 2017 Teladoc, Inc. 4Q Beat and Mixed Guide, Investment Thesis Intact, Reiterate OP, PT to $28 Digital Health TDOC Buy Steven Wardell Register
March 02, 2017 Gazit Globe Deconsolidates EQY following the completion of REG merger, sells 3.7% in FCR Israeli Equities GZT.IT Buy Lena Rogovin Register
March 03, 2017 AveXis, Inc. AVXS (Buy, $100) catalyst alerts: AAN plenary for AVXS-101, mfn, FDA meetings Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
March 05, 2017 Benefitfocus, Inc. Estimates Update Post 4Q16 Digital Health BNFT Buy Steven Wardell Register
March 06, 2017 Viral News in Gene Therapy: Rise and fall for CAR-T; GT PRIME time continues Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
March 06, 2017 IONS: Reiterate concerns of platelet loss, due to discontinuations in APPROACH Biotechnology and Pharmaceuticals Madhu Kumar, PhD Register
March 06, 2017 The Medicines Company MDCO: PT to $80 (from $65) on a higher long-term EBIT margin assumptoin Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
March 06, 2017 Ophthotech Corporation OPHT (Neutral): PT to $4 (from $15) on shift to DCF modeling post FY16 results Biotechnology and Pharmaceuticals OPHT Neutral Gbola Amusa, MD, CFA Register
March 06, 2017 Amicus Therapeutics, Inc. FOLD (Buy): PT maintained at $12.50 after FY16 results update Biotechnology and Pharmaceuticals FOLD Buy Gbola Amusa, MD, CFA Register
March 07, 2017 OncoCyte Corporation OCX: Positive Results From Verification Study of Lung Cancer Diagnostic Test. Therapeutics, Devices & Diagnostics OCX Buy Keay Nakae, CFA Register
March 07, 2017 Vuzix Corp. Strong Start to 2017 from M300 and Toshiba Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
March 07, 2017 The Medicines Company MDCO (Buy): PT to $80 (from $65) on a higher long-term EBIT margin assumption Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
March 07, 2017 22nd Century Group, Inc. Moving Forward with the FDA Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
March 07, 2017 Covata Limited Reduce Estimates. Lower Recommendation Industrial & Consumer Technology CVT:AU Neutral JAMES McILREE, CFA Register
March 08, 2017 Alliqua Inc. ALQA: Tactical Strategy Adjustments After Failure to Acquire Soluble Systems Therapeutics, Devices & Diagnostics ALQA Buy Keay Nakae, CFA Register
March 09, 2017 Profire Energy Inc. December Quarter Preview Industrial & Consumer Technology PFIE Buy JAMES McILREE, CFA Register
March 09, 2017 The KEYW Holding Corporation Q4 Results. Acquisition of Sotera Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
March 09, 2017 22nd Century Group, Inc. Q4 Revenue Exceeds Expectations Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
March 09, 2017 Check-Cap Ltd. CHEK: Progressing Towards Completion of Enrollment in CE Mark Study Therapeutics, Devices & Diagnostics CHEK Buy Keay Nakae, CFA Register
March 10, 2017 Profire Energy Inc. Profire Posts Strong December Quaarter Results Industrial & Consumer Technology PFIE Buy JAMES McILREE, CFA Register
March 10, 2017 22nd Century Group, Inc. Q4 Review. Focusing on Regulatory Relief Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
March 10, 2017 Cogint, Inc. Q4 Better than Expected. Guidance Raised. Industrial & Consumer Technology COGT Buy JAMES McILREE, CFA Register
March 10, 2017 Profire Energy Inc. Profire Posts Strong December Quarter Results Industrial & Consumer Technology PFIE Buy JAMES McILREE, CFA Register
March 10, 2017 La Jolla Pharmaceutical Company LJPC (Buy, PT$90): Increased confidence into full ATHOS-3 results ahead Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
March 10, 2017 ORBCOMM, Inc. AMSA Formally Announced Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
March 10, 2017 Signal Genetics, Inc. SGNL: Dropping Coverage Therapeutics, Devices & Diagnostics SGNL Buy Keay Nakae, CFA Register
March 10, 2017 ORBCOMM, Inc. AMSA Formally Announced Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
March 12, 2017 Viral News in Gene Therapy: IONS down on platform risk (a + for ALNY, AVXS) Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
March 13, 2017 Profire Energy Inc. Profire: Raising Estimates and Price Target Industrial & Consumer Technology PFIE Buy JAMES McILREE, CFA Register
March 13, 2017 U.S. Geothermal Inc. US Geothermal Q4 Review Industrial & Consumer Technology HTM Neutral JAMES McILREE, CFA Register
March 13, 2017 Cogint, Inc. Cogint Q4 Review. Raising EBITDA Estimates Industrial & Consumer Technology COGT Buy JAMES McILREE, CFA Register
March 13, 2017 Sunworks, Inc. Sunworks. Q4 Miss. Lower to Neutral Industrial & Consumer Technology SUNW Neutral JAMES McILREE, CFA Register
March 15, 2017 Clovis Oncology, Inc. Reiterate Sell: [+] SOLO-2 data (AZN) highlights competitive risks in PARPi Biotechnology and Pharmaceuticals CLVS Sell Madhu Kumar, PhD Register
March 15, 2017 Aralez Pharmaceuticals Inc. ARLZ: Significant Downward Reset of Forward Revenue Assumptions Therapeutics, Devices & Diagnostics Aralez Buy Keay Nakae, CFA Register
March 15, 2017 Benefitfocus, Inc. Analyst Day Features Product Launches, Healthcare Reform, Reit. Buy Digital Health BNFT Buy Steven Wardell Register
March 15, 2017 Voyager Therapeutics, Inc. VYGR (Neutral, + bias): PT to $13 (+18%); better investment horizons are nearer Biotechnology and Pharmaceuticals VYGR Neutral Gbola Amusa, MD, CFA Register
March 16, 2017 ESPR (Neutral): We see better risk/reward on Gemphire Tx (unrated) into ACC.17 Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
March 16, 2017 CaesarStone Sdot-Yam Ltd. Key takeaways from 2016 20F form - quartz market and CSTE market share update Aerospace & Defense CSTE Buy Lena Rogovin Register
March 16, 2017 Alony-Hetz Properties & Investments Ltd. Amot 2016 results and 2017 guidance support our ALHE forecasts Aerospace & Defense ALHE.IT Buy Lena Rogovin Register
March 17, 2017 BioTime, Inc. BTX: Nice Progress on Multiple Fronts Therapeutics, Devices & Diagnostics BTX Buy Keay Nakae, CFA Register
March 17, 2017 AveXis, Inc. AveXis (Buy, PT$100) produces breakthrough, event-free results for AVXS-101 Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
March 17, 2017 Vuzix Corp. Q4 Review Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
March 17, 2017 ACC.17: FOURIER design, SPIRE-2 result expose opportunity for MDCO/ALNY Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
March 19, 2017 Azrieli Group PT raised to ILS195 to reflect NOI from Sarona; 4Q16 preview Aerospace & Defense AZRG IT Neutral Lena Rogovin Register
March 19, 2017 Alnylam Pharmaceuticals, Inc. Largest ever RNAi trial (ORION-1) supports [+] ALNY platform safety profile Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar, PhD Register
March 20, 2017 Vuzix Corp. Q4 Review. 2017 is Pivotal Year for Vuzix. Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
March 20, 2017 Viral News in Gene Therapy: AVXS-101 stays event-free; ACC.17 (+) for MDCO/ALNY Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
March 21, 2017 ORBCOMM, Inc. VA Asset Tracking Contract Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
March 21, 2017 Fox Wizel Ltd Increase PT to ILS82 on better margins, lower net debt Aerospace & Defense FOX.IT Buy Lena Rogovin Register
March 22, 2017 HealthEquity, Inc. 4Q Beat and F2018 Slight Guide Above Street, PT to $53, Reit. Buy Digital Health HQY Buy Steven Wardell Register
March 26, 2017 Viral News in Gene Therapy: ABUS at EASL; BOLD reports XLMTM natural history Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
March 27, 2017 Teladoc, Inc. Incrementally More Positive in View After Investor Meetings with Management Digital Health TDOC Buy Steven Wardell Register
March 27, 2017 CRISPR Therapeutics AG Initiate Buy (PT $23.50): Risk-reward on CRISPR clinical lead offsets IP risks Biotechnology and Pharmaceuticals CRSP Buy Madhu Kumar, PhD Register
March 27, 2017 Editas Medicine, Inc. Initiate Buy (PT $65): Broad IP provides broad gene editing optionality Biotechnology and Pharmaceuticals EDIT Buy Madhu Kumar, PhD Register
March 27, 2017 Intellia Therapeutics, Inc. Initiate Buy (PT $19): Leverage to sector valuation overrides IP risk Biotechnology and Pharmaceuticals NTLA Buy Madhu Kumar, PhD Register
March 27, 2017 ToolGen, Inc. Initiate Buy (PT KRW 162,500): Formidable IP, valuation suggest upside Biotechnology and Pharmaceuticals 199800.KS Buy Madhu Kumar, PhD Register
March 27, 2017 Azrieli Group Good 4Q16 and strong progress in pre-lease rates Aerospace & Defense AZRG IT Neutral Lena Rogovin Register
March 29, 2017 Frutarom Industries Ltd 4Q16: slower organic growth and higher expenses, but will reverse in 2017 Aerospace & Defense FRUT.IT Neutral Lena Rogovin Register
March 29, 2017 Asterias Biotherapeutics, Inc. AST: Spinal Cord Injury Study Data Continues to Look Encouraging Therapeutics, Devices & Diagnostics AST Buy Keay Nakae, CFA Register
March 29, 2017 VistaGen Therapeutics VTGN (Buy): Positive, AV-101 EU IP may go to 2034 for major CNS indications Biotechnology and Pharmaceuticals VTGN Buy Gbola Amusa, MD, CFA Register
March 30, 2017 Ritter Pharmaceuticals, Inc. RTTR: Reports Topline Data From Phase 2b/3 Study Therapeutics, Devices & Diagnostics RTTR Buy Keay Nakae, CFA Register
March 30, 2017 Sunworks, Inc. Q4 Results. New CEO Industrial & Consumer Technology SUNW Neutral JAMES McILREE, CFA Register
March 30, 2017 Nearmap Ltd. Business Update: Growth on Track Industrial & Consumer Technology NEA.AX Buy JAMES McILREE, CFA Register
March 30, 2017 GenSight Biologics Initiate Buy (PT€35): Seeing 5x upside potential on eye-catching GS010 data Biotechnology and Pharmaceuticals SIGHT FP Buy Gbola Amusa, MD, CFA Register
March 30, 2017 Adverum Biotechnologies, Inc. ADVM (Neutral): PT to $3.50 on AAV portfolio realloc. on sector initiation Biotechnology and Pharmaceuticals ADVM Neutral Gbola Amusa, MD, CFA Register
March 30, 2017 Dimension Therapeutics, Inc. DMTX (Neutral): PT to $2.25 on AAV portfolio realloc. on sector initiation Biotechnology and Pharmaceuticals DMTX Neutral Gbola Amusa, MD, CFA Register
April 02, 2017 Medical Transcription Billing, Corp. MTBC: Company Reports Q4 Results Healthcare MTBC Buy Keay Nakae, CFA Register
April 02, 2017 Strauss Group Ltd. 4Q16: Strong Coffee, weak Sabra; buying TPG stake is positive; PT up to ILS69 Israeli Equities STRS Neutral Lena Rogovin Register
April 02, 2017 Viral News in Gene Therapy: NVS and KITE are racing CAR-T to the finish line Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
April 03, 2017 BCommunication Ltd. PT downgrade to ILS91 on lower BEZQ, keep BUY on target NAV discount Israeli Equities BCOM.IT Buy Lena Rogovin Register
April 04, 2017 Arbutus Biopharma Corporation Upgrade to Buy (PT $6): Three reasons for cautious optimism in HBV therapy Biotechnology and Pharmaceuticals ABUS Buy Madhu Kumar, PhD Register
April 05, 2017 Gazit Globe More structural changes in 2017 with continued focus on direct ownership Aerospace & Defense GZT.IT Buy Lena Rogovin Register
April 05, 2017 Reform: TrumpCare Will Return; Contracting Pause Incrementally Worse Digital Health Steven Wardell Register
April 06, 2017 Frutarom Industries Ltd CEO interview: focus on smaller acquisitions and EM Aerospace & Defense FRUT.IT Neutral Lena Rogovin Register
April 06, 2017 Rami Levy Shivuk Hashikma Same store sales continued to decline in 4Q16, trend to reverse in 2017 Aerospace & Defense RMLI IT Buy Lena Rogovin Register
April 10, 2017 Viral News in Gene Therapy: ONCE shows reassuring safety in hemophilia B Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
April 10, 2017 Globalstar Inc. Globalstar Up on Straight Path take-out Industrial & Consumer Technology GSAT Buy JAMES McILREE, CFA Register
April 10, 2017 AveXis, Inc. AVXS (Buy): PT to $102.50 (from $100) on housekeeping updates Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
April 10, 2017 La Jolla Pharmaceutical Company LJPC (Buy, PT$90): Management refutes a bear argument Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
April 10, 2017 REGENXBIO Inc. RGNX (Buy): PT to $50 (+43%); conviction on the landmark Danos appointment Biotechnology and Pharmaceuticals RGNX Buy Gbola Amusa, MD, CFA Register
April 10, 2017 Dimension Therapeutics, Inc. DMTX (Neutral): PT$2.25 affirmed, after housekeeping updates Biotechnology and Pharmaceuticals DMTX Neutral Gbola Amusa, MD, CFA Register
April 12, 2017 Lion Biotechnologies, Inc. Reiterate Buy on improved TIL therapy clinical visibility driving 2017 upside Biotechnology and Pharmaceuticals LBIO Buy Madhu Kumar, PhD Register
April 12, 2017 La Jolla Pharmaceutical Company LJPC (Buy): PT to $85 (from $90) on modeling effects of equity offering Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
April 13, 2017 CRISPR patent appeal started; we still favor Broad (EDIT) over UC (CRSP/NTLA) Biotechnology and Pharmaceuticals Madhu Kumar, PhD Register
April 17, 2017 Akari Therapeutics PLC Reiterate Sell (PT to $6.50) due to continued skepticism on coversin in PNH Biotechnology and Pharmaceuticals AKTX Sell Madhu Kumar, PhD Register
April 17, 2017 Viral News in Gene Therapy: CRISPR appeal filed; CRISPR-Cpf1 data in DMD Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
April 20, 2017 Rami Levy Shivuk Hashikma City discounters is a next growth driver, PT upgrade to ILS188 Aerospace & Defense RMLI IT Buy Lena Rogovin Register
April 23, 2017 ARC-520/521/ARB-1467 EASL data support RNAi's utility in HBV functional cure Biotechnology and Pharmaceuticals Madhu Kumar, PhD Register
April 24, 2017 Viral News in Gene Therapy: RNAi utility in HBV; Glybera put on the shelf Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
April 24, 2017 Akari Therapeutics PLC Reiterate Sell on weak efficacy for coversin in the phase II PNH COBALT trial Biotechnology and Pharmaceuticals AKTX Sell Madhu Kumar, PhD Register
April 25, 2017 U.S. Geothermal Inc. CEO Change Industrial & Consumer Technology HTM Neutral JAMES McILREE, CFA Register
April 25, 2017 Genius Brands International, Inc. Rainbow Rangers on Nick Jr. Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
April 25, 2017 Benefitfocus, Inc. Revised Estimates Update Post 4Q16 Digital Health BNFT Buy Steven Wardell Register
April 26, 2017 AveXis, Inc. AveXis (Buy): AVXS-101 patient videos lead to physician applause at AAN 2017 Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
April 26, 2017 The Medicines Company MDCO (Buy): First thoughts-Positives in inclisiran phase III and CVOT program Biotechnology and Pharmaceuticals MDCO Buy Gbola Amusa, MD, CFA Register
April 26, 2017 Alnylam Pharmaceuticals, Inc. 24-month patisiran phase II OLE data address two bear concerns for APOLLO Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar, PhD Register
April 27, 2017 Iridium Communications Inc. Q1 in Line Industrial & Consumer Technology IRDM Neutral JAMES McILREE, CFA Register
April 28, 2017 Benefitfocus, Inc. 1Q Beat, Reaff. Guidance, Reit. Buy, PT to $36 Digital Health BNFT Buy Steven Wardell Register
April 28, 2017 U.S. Geothermal Inc. Raft River on Track for Q3 Expansion Industrial & Consumer Technology HTM Neutral JAMES McILREE, CFA Register
May 01, 2017 Viral News in Gene Therapy: GT PRIME time continues; ASGCT preview Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
May 01, 2017 22nd Century Group, Inc. FDA Authorized Brand B Clinical Study Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
May 01, 2017 Spring Bank Pharmaceuticals Initiate Buy (PT $16.50): 8 reasons SBPH can lead hep B, STING agonist spaces Biotechnology and Pharmaceuticals SBPH Buy Madhu Kumar, PhD Register
May 02, 2017 AB Science S.A. AB.PA: Focus Now on ALS Data Presentation at ENCALS Later This Month Therapeutics, Devices & Diagnostics AB.PA Buy Keay Nakae, CFA Register
May 02, 2017 OncoCyte Corporation OCX: Key Data Presentation on Deck Therapeutics, Devices & Diagnostics OCX Buy Keay Nakae, CFA Register
May 02, 2017 The KEYW Holding Corporation Q1 Preview. Sotera Acquisition Accelerates IC Penetration Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
May 02, 2017 iPass Inc. Q1 Preview. Looking for Continued progress on transition to new service plan Industrial & Consumer Technology IPAS Neutral JAMES McILREE, CFA Register
May 02, 2017 ORBCOMM, Inc. Expect 10% Top Line Growth and 19% EBITDA Growth in Q1 Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
May 02, 2017 Emergent BioSolutions, Inc. EBS: Q1 2017 Earnings Preview Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
May 03, 2017 NICE-Systems Ltd. 1Q17 results preview Aerospace & Defense NICE Buy Lena Rogovin Register
May 03, 2017 Globalstar Inc. Q1 Preview. TLPS Remains Key to Valuation Industrial & Consumer Technology GSAT Buy JAMES McILREE, CFA Register
May 03, 2017 Lion Biotechnologies, Inc. Reiterate Buy (PT to $20): Why LBIO is the leader in precision immuno-oncology Biotechnology and Pharmaceuticals LBIO Buy Madhu Kumar, PhD Register
May 03, 2017 Arrowhead Pharmaceuticals, Inc. ARWR (Neutral): PT to $1.25 (from $2) on housekeeping updates Biotechnology and Pharmaceuticals ARWR Neutral Madhu Kumar, PhD Register
May 04, 2017 The KEYW Holding Corporation Q1 Less than Expected on Product Sale Push-outs Industrial & Consumer Technology KEYW Buy JAMES McILREE, CFA Register
May 04, 2017 Elbit Systems Ltd Diversified Play on Expectations of Rising Defense Budgets Aerospace & Defense ESLT Neutral Lena Rogovin Register
May 04, 2017 iPass Inc. Q1 Revenue a Bit Shy of Estimates. ACV Lower than Expected. Industrial & Consumer Technology IPAS Neutral JAMES McILREE, CFA Register
May 04, 2017 ORBCOMM, Inc. Solid Q1 Results. Higher Hardware Deployments Drives Higher Service Revenue. Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
May 04, 2017 Globalstar Inc. Q1 Better than Expected. International Applications Double TLPS Coverage Industrial & Consumer Technology GSAT Buy JAMES McILREE, CFA Register
May 05, 2017 Emergent BioSolutions, Inc. EBS: Outlook Remains Unchanged After Relatively Uneventful Quarter Therapeutics, Devices & Diagnostics EBS Buy Keay Nakae, CFA Register
May 05, 2017 WageWorks, Inc. Beat and raise and strong selling season, reit OP, PT $87 Digital Health WAGE Buy Steven Wardell Register
May 05, 2017 Alnylam Pharmaceuticals, Inc. Reiterate Buy (PT to $95): How to assess possible NEURO-TTR outcomes Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar, PhD Register
May 08, 2017 NICE-Systems Ltd. 1Q17 EPS above forecast, management raises FY guidance Aerospace & Defense NICE Buy Lena Rogovin Register
May 08, 2017 AB Science S.A. AB.PA: FDA Approves New Drug From Competitor to Treat ALS Therapeutics, Devices & Diagnostics AB.PA Buy Keay Nakae, CFA Register
May 08, 2017 KVH Industries Inc. Q1 Preview. 2017 is Transition Year Industrial & Consumer Technology KVHI Neutral JAMES McILREE, CFA Register
May 08, 2017 Viral News in Gene Therapy: All eyes on ARVO/ASGCT; more big-cap GT activity Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
May 09, 2017 Teladoc, Inc. 2Q Beat, Reaffirm '17 Guide, We See Growing Momentum, Reit. Buy, PT to $30. Digital Health TDOC Buy Steven Wardell Register
May 09, 2017 CaesarStone Sdot-Yam Ltd. 1Q17 preview Aerospace & Defense CSTE Buy Lena Rogovin Register
May 09, 2017 22nd Century Group, Inc. Q1 Exceeds Estimates. Outlook for the Year Raised Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
May 09, 2017 Amicus Therapeutics, Inc. FOLD (Buy): Estimates updated for 1Q17 results; PT unchanged Biotechnology and Pharmaceuticals FOLD Buy Gbola Amusa, MD, CFA Register
May 09, 2017 Arbutus Biopharma Corporation ABUS (Buy): Estimates updated for 1Q17 results; PT unchanged Biotechnology and Pharmaceuticals ABUS Buy Madhu Kumar, PhD Register
May 09, 2017 Spark Therapeutics, Inc. ONCE (Neutral): PT to $60 (from $55) after model updates for 1Q17 results Biotechnology and Pharmaceuticals ONCE Neutral Gbola Amusa, MD, CFA Register
May 10, 2017 Aralez Pharmaceuticals Inc. ARLZ: Management Takes Further Action to Right The Ship Therapeutics, Devices & Diagnostics Aralez Buy Keay Nakae, CFA Register
May 10, 2017 KVH Industries Inc. Q1 Results in Line with Expectations Industrial & Consumer Technology KVHI Neutral JAMES McILREE, CFA Register
May 10, 2017 22nd Century Group, Inc. Q1 Beat and Raise. Multiple Catalysts Pending Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register
May 10, 2017 Cogint, Inc. Q1 Better than Expected Industrial & Consumer Technology COGT Buy JAMES McILREE, CFA Register
May 10, 2017 Vuzix Corp. Q1 Preview. 2017 Pivotal Year for Vuzix Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
May 11, 2017 BioTime, Inc. BTX: Encouraging Results in Dry AMD Study Therapeutics, Devices & Diagnostics BTX Buy Keay Nakae, CFA Register
May 11, 2017 Ritter Pharmaceuticals, Inc. RTTR: On Deck - End of Phase 2 Meeting With The FDA Therapeutics, Devices & Diagnostics RTTR Buy Keay Nakae, CFA Register
May 11, 2017 Novavax, Inc. Untitled Therapeutics, Devices & Diagnostics NVAX Neutral Keay Nakae, CFA Register
May 11, 2017 CaesarStone Sdot-Yam Ltd. Strong 1Q17 sales, low GM; PT up to $43; downgrade to Neutral on valuation Aerospace & Defense CSTE Neutral Lena Rogovin Register
May 11, 2017 Profire Energy Inc. Q1: Everything Better than Expected Industrial & Consumer Technology PFIE Buy JAMES McILREE, CFA Register
May 11, 2017 Vuzix Corp. Q1 Results: M300, Toshiba and More OEMs Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
May 12, 2017 Asterias Biotherapeutics, Inc. AST: New MRI Data Provides Additional Support to Spinal Cord Indication Healthcare AST Buy Keay Nakae, CFA Register
May 12, 2017 Dicerna Pharmaceuticals, Inc. DRNA (Neutral): Estimates updated for 1Q17 results; PT unchanged Biotechnology and Pharmaceuticals DRNA Neutral Madhu Kumar, PhD Register
May 12, 2017 AB Science S.A. AB.PA: Our Initial Take on Action Taken By ANSM Healthcare AB.PA Buy Keay Nakae, CFA Register
May 15, 2017 Viral News in Gene Therapy: Rise and fall in hemophilia; ARVO/ASGCT recaps Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
May 15, 2017 Profire Energy Inc. Raising Estimates Industrial & Consumer Technology PFIE Buy JAMES McILREE, CFA Register
May 15, 2017 U.S. Geothermal Inc. Q1 In Line. Positioned for Growth in 2018 Industrial & Consumer Technology HTM Neutral JAMES McILREE, CFA Register
May 15, 2017 Alnylam Pharmaceuticals, Inc. PT to $110 (+16%): [+] efficacy, [-] safety in NEURO-TTR de-risks APOLLO Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar, PhD Register
May 15, 2017 Sunworks, Inc. Q1 In line. Strong Order Book and Backlog Industrial & Consumer Technology SUNW Neutral JAMES McILREE, CFA Register
May 15, 2017 Medical Transcription Billing, Corp. MTBC: Heading Back Towards Positive Adjusted EBITDA Therapeutics, Devices & Diagnostics MTBC Buy Keay Nakae, CFA Register
May 16, 2017 Check-Cap Ltd. CHEK: On Deck - Topline Data From EU Study Therapeutics, Devices & Diagnostics CHEK Buy Keay Nakae, CFA Register
May 16, 2017 Elbit Systems Ltd 1Q17 backlog up 4.3% y-o-y, EBIT margin affected by higher M&S expenses Aerospace & Defense ESLT Neutral Lena Rogovin Register
May 16, 2017 Social Reality, Inc. Q1 Expected to Be Low Water Mark Industrial & Consumer Technology SRAX Buy JAMES McILREE, CFA Register
May 16, 2017 uniQure N.V. QURE (Buy): PT$12.50 from €12 on model conversion to $ on accounting change Biotechnology and Pharmaceuticals QURE Buy Gbola Amusa, MD, CFA Register
May 17, 2017 Genius Brands International, Inc. Q1 Results. Building for Llama Llama Release This Year and Rainbow Rangers Next Industrial & Consumer Technology GNUS Buy JAMES McILREE, CFA Register
May 17, 2017 Vascular Biogenics Ltd. VBLT (Buy): PT$20 affirmed post 1Q17 results and model updates Biotechnology and Pharmaceuticals VBLT Buy Gbola Amusa, MD, CFA Register
May 18, 2017 Delta Galil Industries Ltd. 1Q17: no organic growth, high opex, 2H17 should be stronger Aerospace & Defense DELTY Neutral Lena Rogovin Register
May 18, 2017 Lion Biotechnologies, Inc. Reiterate Buy: ASCO data, while early, shows [+] TIL efficacy in melanoma Biotechnology and Pharmaceuticals LBIO Buy Madhu Kumar, PhD Register
May 18, 2017 REGENXBIO Inc. REGENXBIO management call (CEO Mills, CSO Danos): Key takeaways Biotechnology and Pharmaceuticals RGNX Buy Gbola Amusa, MD, CFA Register
May 18, 2017 La Jolla Pharmaceutical Company ALERT: ATHOS-3 to be published in NEJM (21 May 2017) and presented at ATS Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
May 18, 2017 Model N, Inc. Helping Pharma Boost Revenue, Initiate at Buy, PT $16 Digital Health MODN Buy Steven Wardell Register
May 18, 2017 AB Science S.A. AB.PA: What We Learned About Phase 3 ALS Data Presented at ENCALS Therapeutics, Devices & Diagnostics AB.PA Buy Keay Nakae, CFA Register
May 19, 2017 Fox Wizel Ltd 1Q17: healthy revenue growth, operating loss on seasonally low GM Aerospace & Defense FOX.IT Buy Lena Rogovin Register
May 19, 2017 HealthEquity, Inc. Adjusting cost of sales for 1-time expenses in F1-2Q18E Digital Health HQY Buy Steven Wardell Register
May 20, 2017 Catasys Inc. Split adjustments Therapeutics, Devices & Diagnostics CATS Buy Keay Nakae, CFA Register
May 21, 2017 Catasys Inc. CATS: Company Rolls-Out Aggressive New Financial Metrics Therapeutics, Devices & Diagnostics CATS Buy Keay Nakae, CFA Register
May 21, 2017 BCommunication Ltd. 1Q17 - neutral for our view, maintain BUY on valuations Aerospace & Defense BCOM.IT Buy Lena Rogovin Register
May 22, 2017 Ituran Location and Control Ltd 1Q17: Strong revenue growth; Raise PT to $33 Aerospace & Defense ITRN Buy Lena Rogovin Register
May 22, 2017 La Jolla Pharmaceutical Company Positive: ATHOS-3 hits on key primary and secondary endpoints in the NEJM Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
May 22, 2017 Viral News in Gene Therapy: First BLA filed in AAV GT; ASCO ahead Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
May 22, 2017 Model N, Inc. Fix EPS Error Digital Health MODN Buy Steven Wardell Register
May 22, 2017 OncoCyte Corporation OCX: Company Presents Positive Data For Lung Cancer Diagnostic Test at ATS Therapeutics, Devices & Diagnostics OCX Buy Keay Nakae, CFA Register
May 23, 2017 OncoCyte Corporation OCX: Increasing Our Price Target to $7.75 Therapeutics, Devices & Diagnostics OCX Buy Keay Nakae, CFA Register
May 23, 2017 Gazit Globe Mixed 1Q17; healthy operating growth, net loss on ILS2 bn non-cash expense Aerospace & Defense GZT.IT Buy Lena Rogovin Register
May 24, 2017 Vascular Biogenics Ltd. VBLT (Buy): ALERT—A new, interesting VB-111 data cut to consider at ASCO 2017 Biotechnology and Pharmaceuticals VBLT Buy Gbola Amusa, MD, CFA Register
May 24, 2017 Azrieli Group 1Q17: NOI in-line, strong FFO; no changes to our view Aerospace & Defense AZRG IT Neutral Lena Rogovin Register
May 24, 2017 AB Science S.A. AB.PA: Takeaways From Today's Investor Call on ALS Phase 3 Data Therapeutics, Devices & Diagnostics AB.PA Buy Keay Nakae, CFA Register
May 24, 2017 Spring Bank Pharmaceuticals PT to $34 (+106%): SB 9200 low-dose data raises the game for HBV immunotherapy Biotechnology and Pharmaceuticals SBPH Buy Madhu Kumar, PhD Register
May 24, 2017 Frutarom Industries Ltd Strong 1Q17; PT up to ILS229, maintain Neutral Aerospace & Defense FRUT.IT Neutral Lena Rogovin Register
May 29, 2017 Rami Levy Shivuk Hashikma No margin improvement in 1Q17; PT up to ILS195 on higher net cash position Aerospace & Defense RMLI IT Buy Lena Rogovin Register
May 29, 2017 Model N, Inc. More Confident After Investor Conference, Reiterate Buy, Reiterate PT $16 Digital Health MODN Buy Steven Wardell Register
May 29, 2017 La Jolla Pharmaceutical Company LJPC (Buy): Neutralizing a key bear argument post ATHOS-3's NEJM publication Biotechnology and Pharmaceuticals LJPC Buy Gbola Amusa, MD, CFA Register
May 30, 2017 Viral News in Gene Therapy: GT payment consortium forming; KITE PDUFA date set Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
May 30, 2017 Assembly Biosciences Initiate Buy (PT $35): How core inhibition can transform hepatitis B therapy Biotechnology and Pharmaceuticals ASMB Buy Madhu Kumar, PhD Register
May 30, 2017 CRISPR mutation paper fails to reflect pipeline approaches; buy on weakness Biotechnology and Pharmaceuticals Madhu Kumar, PhD Register
May 31, 2017 Akari Therapeutics PLC Upgrade to Neutral (PT to $6) on 30% under-performance vs S&P Biotech Index Biotechnology and Pharmaceuticals AKTX Neutral Madhu Kumar, PhD Register
May 31, 2017 Amicus Therapeutics, Inc. Positive—Future SD-101 priority review voucher could be sold for $125-$350 mm Biotechnology and Pharmaceuticals FOLD Buy Gbola Amusa, MD, CFA Register
June 01, 2017 Strauss Group Ltd. 1Q17: Strong Israel and Coffee sales; buys additional 15% in HSW JV Aerospace & Defense STRS Neutral Lena Rogovin Register
June 01, 2017 Biocept, Inc. BIOC: Pure Play Liquid Biopsy Story Therapeutics, Devices & Diagnostics BIOC Buy Keay Nakae, CFA Register
June 04, 2017 Alony-Hetz Properties & Investments Ltd. No surprises in 1Q17; Raise PT to ILS40 on updated valuations Aerospace & Defense ALHE.IT Buy Lena Rogovin Register
June 05, 2017 Viral News in Gene Therapy: Givosiran (ALNY) receives BTD; ASCO is here Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
June 05, 2017 Lion Biotechnologies, Inc. Reiterate Buy: 1st ASCO thoughts show [+] TIL data in post-PD-1/CTLA-4 melanoma Biotechnology and Pharmaceuticals LBIO Buy Madhu Kumar, PhD Register
June 05, 2017 Castlight Health, Inc. The New Health Benefit Hub for the Enterprise, Initiate at Buy, PT $4.50 Digital Health CSLT Buy Steven Wardell Register
June 06, 2017 HealthEquity, Inc. 1Q In-Line and Raise on Strong Execution, Reit. Buy, PT to $57 Digital Health HQY Buy Steven Wardell Register
June 12, 2017 Catalyst Biosciences, Inc. Initiate Buy (PT $10): SubQ hemophilia therapies provide two upside drivers Biotechnology and Pharmaceuticals CBIO Buy Madhu Kumar, PhD Register
June 12, 2017 Viral News in Gene Therapy: AVXS expands pipeline; highlights from ASCO Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
June 12, 2017 Alnylam Pharmaceuticals, Inc. Reiterate Buy: Newly granted IP could block IONS next-gen GalNAc/LICA TTR ASO Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar, PhD Register
June 12, 2017 ORBCOMM, Inc. inthinc Acquisiton has Significant Implications for Growth Industrial & Consumer Technology ORBC Buy JAMES McILREE, CFA Register
June 12, 2017 Alnylam Pharmaceuticals, Inc. Reiterate Buy: Newly granted IP could possibly block IONS' entire TTR franchise Biotechnology and Pharmaceuticals ALNY Buy Madhu Kumar, PhD Register
June 13, 2017 Regulus Therapeutics, Inc. PT to $2.50 (-50%): Program discontinuations balanced by near-cash valuation Biotechnology and Pharmaceuticals RGLS Buy Madhu Kumar, PhD Register
June 13, 2017 Asterias Biotherapeutics, Inc. AST: Interim Data From SCiStar Study Continue to Be Encouraging Therapeutics, Devices & Diagnostics AST Buy Keay Nakae, CFA Register
June 14, 2017 Catalyst Biosciences, Inc. Reiterate Buy: CB 2679d phase I/II supports valuation potential in hemophilia Biotechnology and Pharmaceuticals CBIO Buy Madhu Kumar, PhD Register
June 15, 2017 AveXis, Inc. AVXS (Buy): Aligned with FDA on GMP commercial manufacturing for AVXS-101 Biotechnology and Pharmaceuticals AVXS Buy Gbola Amusa, MD, CFA Register
June 15, 2017 BioTime, Inc. BTX: Renevia Achieves Primary Endpoint in CE Mark Pivotal Trial Therapeutics, Devices & Diagnostics BTX Buy Keay Nakae, CFA Register
June 17, 2017 Aldeyra Therapeutics, Inc. ALDX: Dropping Coverage Therapeutics, Devices & Diagnostics ALDX D Keay Nakae, CFA Register
June 17, 2017 Alliqua Inc. ALQA: Dropping Coverage Therapeutics, Devices & Diagnostics ALQA D Keay Nakae, CFA Register
June 19, 2017 TiGenix Inc. TIG: On Track For EMA Approval By Year-End Therapeutics, Devices & Diagnostics TIG.BR Buy Keay Nakae, CFA Register
June 19, 2017 Viral News in Gene Therapy: AveXis aligns with the FDA on manufacturing Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
June 19, 2017 Azrieli Group Key takeaways from the analyst day: strong development progress Aerospace & Defense AZRG IT Neutral Lena Rogovin Register
June 19, 2017 Clovis Oncology, Inc. Upgrade to Neutral (PT to $50): ARIEL3 data [+] but IP, indication risks remain Biotechnology and Pharmaceuticals CLVS Neutral Madhu Kumar, PhD Register
June 19, 2017 Hansa Medical AB Initiate Buy (PT SEK 400): IdeS can disrupt the kidney transplantation market Biotechnology and Pharmaceuticals HMED.SS Buy Madhu Kumar, PhD Register
June 20, 2017 Vuzix Corp. M300 Off Pre-Order. Blade Production Later this Year. Industrial & Consumer Technology VUZI Buy JAMES McILREE, CFA Register
June 20, 2017 Teladoc, Inc. We Like Annc. of Best Doctors Acq., PT to $41 on Mult. Expansion Digital Health TDOC Buy Steven Wardell Register
June 20, 2017 Vascular Biogenics Ltd. VBLT (Buy): 1 drug, 3 long-term OS signals, in 3 tumor types Biotechnology and Pharmaceuticals VBLT Buy Gbola Amusa, MD, CFA Register
June 20, 2017 NVS (Buy), REGN (Neutral): RTH258 hits on key endpoints in phase III studies Biotechnology and Pharmaceuticals Gbola Amusa, MD, CFA Register
June 21, 2017 Elbit Systems Ltd IMI privatization process resumed, ESLT is the sole contender Aerospace & Defense ESLT Neutral Lena Rogovin Register
June 21, 2017 GenSight Biologics SIGHT (Buy): Why 96-week GS010 phase I/II data in LHON ND4 are promising Biotechnology and Pharmaceuticals SIGHT FP Buy Gbola Amusa, MD, CFA Register
June 22, 2017 22nd Century Group, Inc. Working with FDA on Multiple Paths to Commercialization Industrial & Consumer Technology XXII Buy JAMES McILREE, CFA Register